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Coronary Heart Disease (CHD) is the most important clinical manifestation of 
atherosclerosis. The most prominent risk factor for development of atherosclerosis is 
hypercholesterolemia. Lower serum cholesterol is believed to have lower risk of CHD. 
The present thesis project studied effects of chemical cholesterol incorporated into 
high cholesterol diets on serum cholesterol level in rats (Sprague-Dawley rat) and 
hamsters (Golden Syrian hamsters, Mesocricetus auratus). It was found that the rats 
were hypo-responsive to dietary cholesterol but hamsters were hyper-responsive. 
The first part of study investigated the molecular mechanism by which rats and 
hamsters had different response toward dietary cholesterol. The present study 
examined the following proteins/mRNAs, which involved in cholesterol metabolism: 
(a) nuclear form of sterol regulatory element-binding protein-2 (nSREBP-2), which 
regulates gene expression of protein/enzymes involved in cholesterol homeostasis; (b) 
LDL-receptor, which mediates the removal of circulating cholesterol; and (c) 
HMG-CoA reductase, which is a key enzyme in cholesterol synthesis; (d) CYP7A1, 
which is a regulatory enzyme in conversion of cholesterol to bile acids; and (e) 
LXR-a, which is the positive regulator of CYP7A1. Western blot showed that 
nSREBP-2, LDL-receptor, and CYP7A1 expression were enhanced in rats but not in 
hamsters when dietary cholesterol increased. Northern blot further confirmed that the 
up-regulation of LDL-receptor and CYP7A1 occurred at transcription level in rats, by 
nSREBP-2 and LXR-a respectively. Taken together, the present results demonstrated 
that rats were hypo-responsive to dietary cholesterol because excess cholesterol in 
blood was transported by LDL-receptor into the liver and excess cholesterol in the 
liver was excreted as bile acids via CYP7A1 pathway. In contrast, hamsters were 
hyper-responsive because they did not show corresponding change in LDL-receptor 
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and CYP7A1 when exposed to a high dietary cholesterol diet and the cholesterol 
accumulated in blood. 
Most interesting observation was that different responsiveness occurred in the 
same species. The second part of the study was performed to determine the 
mechanism for individual variation of serum cholesterol in response to a same amount 
of dietary cholesterol. The correlation between protein expression of LDL-receptor, 
CYP7A1, nSREBP-2, LXR-a, HMG-CoA reductase and serum total cholesterol was 
investigated in both rats and hamsters. It was found that higher CYP7A1 protein 
expression was linked with lower serum total cholesterol in both rats and hamsters, 
suggesting efficient cholesterol elimination was common for those hypo-responders. 
LDL-receptor protein expression was negative correlated with serum total cholesterol 
in hamsters, implying that high LDL-receptor protein expression was an additional 
mechanism for lowering serum total cholesterol in hamsters. However, no 
correlation of nSREBP-2, LXR-a, HMG-CoA reductase with serum total cholesterol 
was observed in rats or hamsters, indicating that serum total cholesterol level was not 
directly influenced by the expression of these proteins. 
To summarize, both the efficient elimination of cholesterol from the body (via 
CYP7A1 pathway) and the efficient removal of serum cholesterol by LDL-receptor 




冠心病(Coronary Heart Disease, CHD)是動脈粥樣硬化(Atherosclerosis)最重要 
的臨床表現，而高膽固醇症(hypercholesterolemia)是引起動脈粥樣硬化最主要的 
原因。所以，降低血清膽固醇可助於降低冠心病的風險。本硏究比較了大鼠 









是一種膽汁酸驢生物合成的限速酶；（五）肝X受體（Liver X receptor)，它能正相 
調節膽固醇-7a-經基化酶。Western blot的結果顯示大鼠的膽固醇調節元件结合 
蛋白-2、低密度脂蛋白受體和膽固醇-7 a -經基化酶隨膳食中的膽固醇水平升高而 
增加，但倉鼠卻沒有增加。Northern blot的結果進一步證明低密度脂蛋白受體和 
膽固醇-7 a -經基化酶的增加是在轉錄水平的，並分別受核型膽固醇調節元件结合 
蛋白-2及肝X受體調節。總之，我們的數據顯示大鼠對膳食內膽固醇的低反應 
性是由於過多的膽固醇被低密度脂蛋白受體從血液循環轉運至肝臟，進而被膽固 
醇-7 a -經基化酶轉化成膽汁酸疆排出體外。相反，倉鼠的高反應性是由於低密度 
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1.1.1 History of cholesterol 
The cholesterol was first recognized as an alcohol-soluble, readily crystallizable 
component of bile stones by Chevreul in 1816. It was first named "cholesterine" from 
two Greek words: chole, meaning bile, and stereos, meaning solid. In the middle of 
nineteenth century, cholesterin was also identified as a constituent of several normal 
animal tissues and in atheromatous lesions of arteries. The name was changed to 
"cholesterol" in English-speaking countries in the twentieth century. 
1.1.2 Structure of cholesterol 
The structure of cholesterol was elucidated by the researches of Wieland and 
Windaus extending over a quarter of a century and finally established by 
crystallography (Bernal, 1932). Cholesterol is a steroid that built from four linked 
hydrocarbon rings. A hydrocarbon tail is linked to the steroid at one end, and a 
hydroxyl group is attached at the other end. Two angular methyl groups, C-18 and 
C-19, attached to C-13 and C-10 of the hydrocarbon ring, respectively. The C-18 and 
C-19 methyl groups lie above the plane containing the four rings. Figure 1.1 showed 
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Figure 1.1. Chemical structure of cholesterol 
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1.1.3 Biological function of cholesterol 
Cholesterol serves as important component of the cell membrane, precursor of 
steroid hormones and bile acids. As a necessary component of biological membranes, 
cholesterol provides stability that makes the membrane's fluidity stable over a bigger 
temperature interval. This was done by breaking up the Van der Waals interactions 
and the close packing of the phospholipid tails, which makes the membrane more 
fluid. Hence, one way for a cell to control the fluidity of its membrane is by regulating 
its level of cholesterol in the cell membrane. 
Cholesterol is the major precursor for many steroid hormones. Five major classes 
of steroid hormones are derived from cholesterol: progestagens, glucocorticoids, 
mineralocorticoids, androgens, and estrogens. In the adrenal glands, cholesterol is 
converted to Cortisol and aldosterone, which controls the carbohydrate metabolism 
and the body levels of sodium and potassium, respectively. 
Bile acids are mainly produced in the liver with use of cholesterol as the 
precursor. Bile acids assist the solubilization of dietary lipids by increasing the 
effective surface area of lipids. With more surface area, digestion of lipid by lipase 
and absorption by the intestine are more efficient. 
1.1.4 Sources of cholesterol in our body 
There are two sources of cholesterol in the body: endogenous and dietary 
(Kohlmeier, 2003). About 70% of cholesterol inside our body is synthesized 
endogenously. The major sites of production are liver and intestines. Dietary source of 
cholesterol provides the remaining 30% of body cholesterol. The largest source of 
cholesterol in our diet is eggs (4.3 mg/g). Other sources include organ meats, such as 
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liver (3.9 mg/g), and animal fats, such as lard (1.0 mg/g). 
1.2 Lipid hypothesis 
Lipid hypothesis (also called diet-heart hypothesis) was proposed by Keys in the 
late 1950's. The main idea of lipid hypothesis is that lowering blood cholesterol levels 
should significantly reduce the incidence of coronary heart disease (CHD). Many 
research works support this view, for example, Brown et al. (1990) conducted a 
clinical research that suggested low cholesterol in diet reduces the incidence of CHD. 
1.2.1 Relationship between dietary cholesterol and plasma cholesterol 
Dietary cholesterol had a strong linkage with plasma total cholesterol (TC). 
Higher dietary cholesterol intake can lead to a higher TC value. According to one U.S. 
study, the amount of cholesterol in the diet alters the amount in the serum by 
approximately 5 mg/dl for every 100 mg of change in diets (Brown, 1983). Hence, it 
is generally recommended to have a low cholesterol diet in order to prevent CHD. 
Egg is one of the dietary components that had been extensively investigated for its 
effect on blood cholesterol level in experimental animals. It is believed that egg intake 
is a risk factor of CHD because it is rich in dietary cholesterol and high serum 
cholesterol is a risk factor of CHD (Kritchevsky, 2004). 
1.2.2 Hypercholesterolemia，atherosclerosis and coronary heart disease (CHD) 
As mentioned above, dietary cholesterol can cause elevated TC. When the 
cholesterol concentration in plasma is higher than the benchmark, an individual is 
regarded as hypercholesterolemia. In human, plasma cholesterol level over 200mg/dL 
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is regarded as hypercholesterolemia (Perrault et al., 2000). Hypercholesterolemia is a 
risk factor of atherosclerosis. Atherosclerosis is the process of hardening and 
narrowing of blood vessels, which is caused by hypercholesterolemia. Figure 1.2 
shows the stages leading to atherosclerosis. In brief, high cholesterol concentration in 
plasma causes the deposition of plaques in the arteries with the combination of 
cholesterol, other fatty substances, fibrous tissue, and calcium. Until the lipid 
materials accumulate to a certain level, more or less depends on individuals, plaque 
rupture results and causes blockages in the arteries (Deslypere et al, 1998; 
Schettlerballot et al., 1997; Stehbens et al., 1990). When the process occurs in brain, 
stroke occurs; while it occurs in major heart vessels, CHD occurs. 
1.2.3 Individual variation 
Not everyone has the same response to dietary cholesterol. Many studies 
demonstrated that some animals are hyper-responsive (sharp increase in TC) to 
dietary cholesterol while some are hypo-responsive (moderate increase in TC) 
(Beynen et al” 1987; Katan and Beynen, 1987; Jacob et al., 1983). However, the 
mechanisms for the differences in response to dietary cholesterol remain unclear. As 
plasma total cholesterol is associated with incidence of CHD, study on the mechanism 
why some animal are hyper-responsive while some are hypo-responsive to dietary 
cholesterol can help us better understand causes of CHD. 
5 
Figure 1.2. An illustration of the steps involved in atherosclerosis. 
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1.3 Cholesterol homeostasis 
The major site controlling cholesterol homeostasis is liver, which synthesizes and 
contributes almost 70% of body cholesterol. The cholesterol homeostasis is 
maintained by three major mechanisms (Figure 1.3): (a) synthesis of cholesterol, 
which is controlled by a rate-limiting enzyme, 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMG-CoA reductase) (Goldstein and Brown, 1984); (b) uptake of 
circulating blood cholesterol, by low-density lipoprotein receptor (LDL-receptor) 
(Brown and Goldstein, 1986) (c) elimination of cholesterol by converting it to bile 
acids, which is controlled by a rate-determining regulatory enzyme, 
cholesterol-7a-hydroxylase (CYP7A1) (Shefer et al., 1992). The expression of these 
regulatory proteins/enzymes is highly regulated, which under the control of 
transcription factors: SREBP-2 (Goldstein and Brown, 1999; 1997) and LXR-a 
(Gupta et al., 2002). SREBP-2 regulates the expression of LDL-receptor and 
HMG-CoA reductase while LXR-a up-regulates the gene expression of CYP7A1. 
1.3.1 SREBPs up-regulates the expression of LDL-receptor and HMG-CoA 
reductase 
Three isoforms of SREBPs have been identified: SREBP-la, SREBP-lc and 
SREBP-2. SREBP-la and SREBP-lc are produced from a single gene through the use 
of alternative transcription start sites encoding alternative first exons (Shimomura et 
al., 1997). A separate single gene encodes SREBP-2, which is 47% identical to 
SREBP-la (Hua et al., 1993). Although SREBP-la/c and SREBP-2 share similarity 
both in terms of amino acid sequences and structures, the functions of both 
are not identical. SREBP-la/c plays an important role in fatty acid metabolism 
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Figure 1.3. The homeostasis of cholesterol is controlled by liver, via three major 
mechanisms: uptake from blood, elimination in feces and endogenous biosynthesis. 
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whereas SREBP-2 plays a greater regulatory role in cholesterol metabolism. 
SREBPs are synthesized as precursors bound to the endoplasmic reticulum (ER) 
and the nuclear envelop membrane in a hairpain orientation such that the N-terminal 
and C-terminal domains both face the cytoplasm (Osborne, 2000). The N-terminal 
domain SREBPs contains a basic helix-loop-helix leucine zipper (bHLH-ZIP) motif, 
which provides a DNA-binding domain. The precursor form of SREBPs cannot act as 
transcription factor until they are activated so that the N-terminal domain can 
translocate to the nucleus where it activates the transcription of sterol-responsive 
genes involved in cholesterol and fatty acid metabolism (Brown and Goldstein, 1997). 
The activation mechanism of SREBP-2 has been most extensively studied. 
Release is accomplished by a two-step proteolytic cascade (Figure 1.4) that is 
regulated by sterols (Hua et al., 1996; Sakai et al., 1996; Wang et al., 1994). In 
sterol-depleted cells the cascade is initiated by a site-1 protease (SIP) that cleaves the 
middle of the luminal loop between two membrane-spanning domains (site-1 
cleavage). Cleavage at site 1 breaks the covalent bond between the two 
transmembrane domains of SREBP-2, but both halves of the protein remain attached 
to membranes. Shortly thereafter, site-2 protease (S2P) clips the N-terminal of 
SREBP-2, which appears to reside within the first transmembrane domain (Sakai et al., 
1996). This releases the active-form of SREBP-2 into the cytosol, from which it 
rapidly enters the nucleus and act as transcription factor. 
SREBPs are believed as specific transcription factors that bind to lObp sterol 
regulatory element (SRE) within the promoter region of the genes encoding the LDL 
receptor and HMG-CoA reductase (Vallett et al., 1996; Hua et al., 1993; Wang et al., 
1993). Parallel expression of SREBPs and important proteins involved in cholesterol 
homeostasis suggests their important role in the regulation of sterol-responsive genes. 
Generally, when cellular cholesterol is low, SREBPs are activated and act as 
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Figure 1.4. Model for the sterol-mediated proteolytic release of SREBPs from 
membranes. Adapted from Brown and Goldstein (1999). 
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transcription factors binding to genes encoding enzymes in the cholesterol 
biosynthesis pathway. In the study of Wang et al. (1993), it is suggested that 
LDL-receptor, which uptakes cholesterol from plasma LDL through 
receptor-mediated endocytosis, is regulated by SREBPs. 
1.3.2 HMG-CoA reductase as the rate-limiting enzyme in cholesterol synthesis 
HMG-CoA reductase (EC 1.1.1.34) is the rate-determining enzyme that involves , 
in cholesterol biosynthesis (Brown et al., 1973). HMG-CoA reductase is an intrinsic 
membrane protein of the endoplasmic reticulum (ER) that catalyses the synthesis of 
mevalonate (Brown et al., 1974), which is a crucial intermediate in the formation of 
sterols and non-steroid isoprenoid compounds. 
Cholesterol biosynthesis is controlled by the regulation of genes in response to 
intracellular cholesterol levels (Goldstein and Brown, 1990). When cellular 
cholesterol level is low, active forms of SREBPs (via proteolytic cleavage) are 
transported to the nucleus. The SREBPs then bind to SREs in the promoter regions of 
HMG-CoA reductase, thus increasing its transcription. In contrast, when cellular 
cholesterol level is high, the metabolites of cholesterol, such as hydroxyl-cholesterol, 
prevent the proteolytic cleavage of SREBPs to their active form, resulting in the 
down-regulation of HMG-CoA reducatase. 
Since HMG-CoA reductase is responsible for the cholesterol biosynthesis in the 
body, it is believed that inhibition of this enzyme could help to lower blood 
cholesterol. Artificial HMG-CoA reductase inhibitors, such as lovastatin, pravastatin 
and simvastatin, are extensively used to cure patients with hypercholesterolemia. 
Some studies also suggest that water-soluble fibers can lower serum cholesterol 
concentration by inhibiting the activity of HMG-CoA reductase (Kay, 1982). The 
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mechanism for lowing blood cholesterol by inhibiting cholesterol biosynthesis was 
proposed by Brown and Goldstein (1986). When intracellular cholesterol synthesis is 
inhibited, more LDL-receptor is expressed to obtain cholesterol from blood for the 
needs in cells. Therefore, blood cholesterol is lowered by inhibiting HMG-CoA 
reductase. 
1.3.3 LDL-receptor as the major protein removing plasma cholesterol 
( 
Removal of blood cholesterol is mediated by hepatic LDL-receptor, through a 
process called receptor-mediated endocytosis (Brown and Goldstein, 1986; 1984; 
Brown et al., 1981). Figure 1.5 shows the pathway for receptor-mediated endocytosis. 
LDL-receptors on cell-surface recognize the apolipoprotein (apo) B-lOO on low 
density lipoprotein (LDL) and the complex is being internalized in a clathrin-coated 
pit that pinches off to become a coated vesicle. The vesicle containing the LDL 
rapidly loses its clathrin coat and fuses with other similar vesicles, forming larger 
vesicles called endosomes. LDL particle dissociates from LDL-receptors when fuse 
with late endosome, where the pH falls below 6 (Rudenko et al., 2002). The 
LDL-receptors are recycled by forming a separate vesicle and then travel back to the 
plasma membrane. The vesicle containing LDL particle fuses with the lysosome 
where lysosomal hydrolases degrade the apo-B protein to amino acids and release the 
cholesterol in the cellular region (Goldstein et al., 1975). The released free cholesterol 
is used for the production of bile acids, steroid hormones and the cell membrane. 
The regulation of LDL-receptors is supposed to be at transcription level 
(Goldstein and Brown, 1990), in response to cellular free cholesterol concentration. 
As mentioned in the section 1.3.1, promoter of LDL-receptor gene contains an SRE, 
which is the binding site for SREBPs. Low level of cellular cholesterol induces 
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Figure 1.5. Receptor mediated endocytosis pathway of LDL-receptor. Adapted from 
Lodish et al. (2000). 
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transcription of LDL-receptor gene (Hua et al., 1996). Similar finding was observed 
in human mononuclear cells that cholesterol-restricted diet caused an up-regulation of 
LDL-receptor mRNA expression (Boucher et al., 1998). Hence, the up-regulation of 
LDL-receptor, at transcriptional level, seems to be a compensatory mechanism for the 
cholesterol deficiency. 
1.3.4 LXR-a as an activator of CYP7A1 
/ 
LXR-a is expressed mainly in the liver, whereas lower concentrations are 
expressed in the kidney, intestine, spleen and adrenals (Willy et al., 1995). LXR-a was 
first identified as orphan nuclear receptors. They consist of a central DNA-binding 
domain and a hydrophobic C-terminal domain that mediates ligand recognition, 
receptor dimerization and ligand-dependent activation (Peet et al., 1998a). LXR-a is 
activated by naturally occurring oxysterols (Janowski et al., 1996). 
Figure 1.6 shows the process of CYP7A1 up-regulation by LXR-a. To function 
as transcription factors, LXR-a has to heterodimerize with the retinoid X receptors 
(RXRs). This heterodimer can be activated by ligands for either RXR or LXR. 
Binding of ligands to LXR response element (LXRE) in the promoter region induces 
the conformational changes in the LXR-RXR heterodimer, resulting in enhanced 
transcription of a target gene (Willy and Mangelsdorf, 1997). The parallel expression 
pattern of LXR-a and oxysterols indicates LXR-a is involved in cholesterol 
metabolism. For example, up-reguation of LXR-a is associated with enhanced 
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Figure 1.6. LXR-a up-regulates the transcription of CYP7A1 by forming heterodimer 
with RXR and binding to the LXRE of CYP7A1. 
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1.3.5 CYP7A1 controls the classical pathway for the elimination of hepatic 
cholesterol 
CYP7A1 (EC 1.14.13.17) controls the first and rate-limiting step on the catabolic 
pathway from cholesterol to bile acids. It catalyzes the conversion of cholesterol to 
7a-hydroxycholesterol by addition of a hydroxyl group on the C-7 position on 
cholesterol Subsequently, 7a-hydroxycholesterol is modified by more than 17 
enzymes to convert into primary bile acids (Russell, 2003). As bile salts are the major ‘ 
excretory products of cholesterol catabolism (Russell and Setchell, 1992), CYP7A1 
plays an important role in the removal of cholesterol from cell and from the blood 
stream. 
CYP7A1 is regulated positively by cholesterol in the liver and negatively by bile 
acids. In response to increased dietary cholesterol, the hepatic cholesterol pool is 
maintained by an increased conversion of cholesterol to bile acids, via CYP7A1 
pathway, or secretion of free cholesterol into bile. It is interesting to note that the 
extent of bile acid synthesis responding to dietary cholesterol varies among species. 
Dietary cholesterol increases mRNA and activity of CYP7A1 as a compensatory 
response to maintain cholesterol homeostasis in rats (Shefer et a l , 1992; Pandak et al., 
1991). In contrast, repressed mRNA expression and activity of CYP7A1 were 
observed in hamsters feeding cholesterol (Horton et al., 1995). Negative feedback of 
bile acid in CYP7A1 has been demonstrated by many studies. Early study by 
Bergstrom and Danielsson (1958) has showed that injection of bile acids into rats 
caused a rapid reduced rate of bile acids excretion. Subsequent studies by Shefer et al. 
(1970; 1969) have directly indicated that the reduced bile acids excretion after 
injection of taurocholate is due to the blockage of 7a—hydroxylation of cholesterol, 
which is a process controlled by CYP7A1. In contrast, increased CYP7A1 mass, 
16 
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transcription and activity was observed in biliary diverted rats, where bile acids 
reabsorption was inhibited (Parks et al., 1991). Hence, the difference in the extent of 
bile acid synthesis in response to dietary cholesterol in different species may be due to 
different level of bile acids return to the liver, which exerts different level of negative 
inhibition on CYP7A1. 
Clinically, bile acid sequestrants are widely used in the treatment of 
hypercholesterolemia. Two commonly used bile acid sequestrants are cholestyramine 
i 
and colestipol (Wilson et al., 1998). Bile acid sequestrant, such as cholestyramine, 
acts by binding of bile acids in the duodenum, and carried to the ileum and then 
excreted in feces. Diminished pool of bile acids prompts the conversion of more 
hepatic cholesterol into bile acids, by the action of CYP7A1 mentioned above. As a 
result of depletion of liver cholesterol, increased hepatic LDL-receptor activity and 
enhanced LDL clearance from circulation helps in lowering plasma cholesterol levels 
(Ast and Frishman 1990; Packard and Shepherd, 1982). 
1.3.6 Bile acids as the metabolites of CYP7A1 
As mentioned in 1.1.3, bile acids are important metabolites in eliminating 
cholesterol from our body. There are two distinct pathways for the bile acid synthesis: 
the classical (neutral) and the alternative (acidic) pathway. Microsomal cholesterol 
7a-hydrolyase (from CYP7A1 gene) is the rate-limiting enzyme in the classical bile 
acid synthesis, and mitochondrial sterol 27-hydroxylase is suggested to be the limiting 
enzyme in alternative bile acid synthesis. The major pathway of bile acids 
biosynthesis is the classical pathway, which constitute about 80% of the bile acids 
excreted (Russell and Setchell, 1992). 
The catabolism of cholesterol is a process of conversion of cholesterol from a 
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highly water-insoluble lipophilic molecule to a smaller hydrophilic bile acid. The 
conversion process involves multiple hydroxylations of cholesterol structure by a 
series of at least 17 metabolic intermediary enzymatic steps (Russell, 2003). The two 
primary bile acids, chenodeoxycholic and cholic acids, are the most abundant in the 
bile. They are produced by hydroxylations at C-7 or at both C-7 and C-12 on 
cholesterol (Figure 1.7). These two bile acids are synthesized in equal amounts via 
classical (neutral) pathway involving the rate-limiting enzyme, CYP7A1 (Russell, 
I 
2003). Bacterial reactions in the intestine convert primary bile acids into secondary 
bile acids. Chelate and chenodeoxycholate are converted to deoxycholate and 
lithocholate, respectively. In humans, approximately 95% of both primary and 
secondary bile acids are reabsorbed by the intestines and delivered back to the liver 
via the portal circulation, in the process called enterohepatic circulation. This process 
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Figure 1.7. CYP7A1 controls the conversion of cholesterol to 7a-hydroxycholesterol. 
Modified from Jelinek et al.(1990). 
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1.4 Previous works in our laboratory 
It is known that each population has some individuals who are resistant to 
diet-induced hypercholesterolemia and atherosclerosis (Herron et al., 2003; Jacobs et 
al., 1983). This phenomenon has been found also in different animal species (Gao et 
al., 2002; Sullivian et al., 1993). For example, Golden Syrian (GS) hamsters are 
hyper-responders to dietary cholesterol while guinea pigs and Sprague Dawley (SD) 
rats are hypo-responders to high cholesterol diets. 
In order to establish the animal models for studying the mechanisms of hypo- or 
hyper-repsonsive effect to dietary cholesterol, effect of dietary eggs on serum 
cholesterol level in both rats and hamsters were previously studied in this laboratory. 
Interestingly, supplementation of boiled egg in diet (1-2 eggs/2000 kcal or 1.1-1.7 g 
cholesterol/kg diet, equivalent to 1-2 eggs/day/per person in humans) did not raise but 
instead it lowered cholesterol level in SD rats by 24-32%; whereas in hamsters, egg 
supplementation at the same level in diet significantly elevated serum cholesterol 
level by 19-42% (Figure 1.8). These results clearly suggest that two species respond 
very differently to a high cholesterol diet. The observation arouses our interest to 
investigate the underlying mechanisms. It is believed that effect of dietary cholesterol 
on its serum level is a complex process that involves multifaceted dietary 
cholesterol-gene interaction. 
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Figure 1.8. Effect of egg supplementation in diet on serum cholesterol level in rats 
and hamsters (n = 12). Unpublished data in our laboratory. 
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1.5 Objective of this project 
This study focused on how the expression pattern of the above mentioned 
regulatory proteins and its transcription factors in two animal models (SD rats and GS 
hamsters) lead to the different response to dietary cholesterol. 
There are two parts in this project. For the first part of experiment, whether there 
are any differences of proteins/enzymes expression profile in response to high 
cholesterol diets was determined. Rats and hamsters, which act as a hypo-responsive 
and a hyper-responsive model respectively, were chosen in the present study. In 
addition, the level of regulation (transcription or translation) of those important 
proteins/enzymes was determined. The first part of experiment could help us 
understand how the difference in protein/enzyme expression led to different response 
to a high cholesterol diet. 
The second part of the experiment was to establish the relationship of serum 
cholesterol and the expression level of proteins related to cholesterol homeostasis. For 
example, whether higher LDL-receptor expression in some individual leads to a lower 
serum cholesterol. This part of experiment could help explain why some individuals 




Increased expression of LDL-receptor is 
responsible for the hypo-responsiveness of rats 
to dietary cholesterol 
2.1 Introduction 
Hepatic cholesterol is derived from the de novo biosynthesis, which is controlled 
by HMG-CoA reductase (Goldstein and Brown, 1984), and receptor-mediated uptake 
of plasma cholesterol, by the action of LDL-receptor (Brown and Goldstein, 1986). 
LDL-receptors provide hepatocytes with a highly efficient means for supplying 
adequate amount of readily available cholesterol. LDL-receptor recognize apo-B 100 
of plasma LDL and uptake them into the liver, via a process called receptor-mediated 
endocytosis (Brown and Goldstein, 1986). HMG-CoA reductase, a rate-determining 
enzyme for the biosynthesis of cholesterol, provides endogenous source of cholesterol 
when the cellular level of cholesterol is low. It has been demonstrated that 
LDL-receptor and HMG-CoA reductase mRNA are coordinately regulated 
(Rudling,1992). Subsequent studies have shown that the coordination between 
LDL-receptor and HMG-CoA reductase are under the control of SREBP-2 (Goldstein 
and Brown, 1990). When cellular cholesterol level is low, more SREBP-2 is converted 
from precursor form to nuclear form, which binds to the promoter region and 
up-regulate LDL-receptor and HMG-CoA reductase. It has been postulated that 
different responsiveness to dietary cholesterol in animals is, at least partially, due to 
the different expression level of LDL-receptor and HMG-CoA reductase in response 
to high cholesterol diet. 
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2.2 Objective 
Rats were used as a "hypo-responsive" model where hamsters were a 
"hyper-responsive" model to dietary cholesterol in this study. This study was 
performed to determine the differences in the cholesterol uptake and biosynthesis in 
J 
the liver of both animals in the response to a high cholesterol diet. In addition, the 
mechanism for the differences in the protein/enzyme was also determined. 
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2.3 Methods and materials 
2.3.1 Animals 
Sprague-Dawley (SD) rats and Golden Syrian (GS) hamsters were housed in 
cages in a room with controlled temperature (20 — 23�C) and lighting (alternating 12 
hour periods of light and dark). Prior to the studies, the animals were fed a pelletized 
commercial nonpurified diet for 6 days after arrival. The body weight of rats was 190 
to 240 grams while that of the hamsters was 120 to 150 grams. 
The animals were then randomly divided into 4 groups (n = 5) and fed a 
semisynthetic diet (control diet) with or without supplementation of 0.3%, 0.6% or 
0.9% (wt/wt) cholesterol (Sigma Chemical Co. St. Louis, MO) ad libitum for 4 weeks. 
All studies were carried out during the mid-dark phase of the light cycle. The animals 
were killed in a nitrogen gas tank. Liver, white adipose tissue (epididymal), brown 
adipose tissue (interscapular), kidney cortex (separated from the renal medulla), heart, 
skeletal muscle and brain were rapidly removed and frozen in liquid nitrogen. 
2.3.2 Diets 
The control semisynthetic diet used in these studies contained (wt/wt) 10% lard, 
30.5% corn starch, 25.7% sucrose, 24.9% casein, 3.7% AIN-76 mineral mix, 1.1% 
AIN-76 vitamin mix, 0.4% choline bitartrate, 0.3% DL-methionine and 3.4% 
cellulose. The ingredients were purchased from Harlan Teklad (Madison, WI) except 
for lard, which was obtained from the local market, and DL-methionine and 
cholesterol, which were purchased from Sigma Chemical (St. Louis, MO).The 
experimental diets were prepared by supplementing the control semisynthetic diet 
(0.0%) with 0.3%, 0.6% and 0. 9% cholesterol. 
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2.3.3 Determination of serum cholesterol 
Serum total cholesterol (TC) levels was determined enzymatically by the use of 
commercial kits (Sigma Chemical, St Louis, MO, USA). 
2.3.4 Western blot 
The protein was extracted according to the method described by Vaziri et al. 
(1996) with some modifications. Briefly, frozen rat liver was homogenized in lysis 
buffer with 20mM Tris-HCl (pH 7.5) containing 2mM MgCli, 0.2M sucrose and 
protease inhibitor cocktail pellet (Complete, Roche, Mannheim, Germany). The crude 
extract was separated into two aliquots. One was centrifuged at 12,000 rpm for 15 
minutes at 4 � C . The supernatant was considered as total protein fraction. Another 
aliquot was centrifuged at 3,000 rpm for 10 minutes at 4�C. The supernatant was then 
centrifuged at 35,000 rpm for 60 minutes at 4 � C . The solubilized pellet was 
considered as membrane protein fraction. Protein concentration of two fractions was 
determined by using a Bio-Rad Protein Assay kit (Bio-Rad Laboratories, California, 
USA). 
For the measurement of LDL-receptor and HMG-CoA reductase, the membrane 
protein (lOOjig) was size-fractionated on 8 % SDS-PAGE at 120V for two hours. 
After electrophoresis, proteins were transferred to a Hybond-ECL membrane 
(Amersham Life Science Inc., Arlington Heights, IL, USA). The membrane was 
incubated for one hour in blocking solution (Ix TBS, 0.1% Tween-20 and 5% nonfat 
milk) at room temperature and then overnight at 4°C in the same solution containing 
1:300 anti-LDL receptor antibody (Santa Cruz Biotechnology, Inc., California, USA) 
or 1:500 anti-HMG-CoA reductase (Upstate USA Inc., Lake Placid, NY, USA) 
whichever appropriate. Membrane was washed once for 15 minutes then twice for 
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five minutes in washing solution (Ix TBS and 0.1% Tween-20) prior to one hour 
incubation in blocking solution containing diluted (1:3000) horseradish 
peroxidase-linked rabbit anti-goat IgG (Zymed Laboratories Inc., South San Francisco, 
USA) or donkey anti-rabbit IgG (Amersham Life Science Inc., Arlington Heights, IL, 
USA). The washes were repeated before the membranes were developed with 
chemiluminescent agents (ECL; Amersham Life Science) and subjected to 
autoradiography for one to five minutes. 
For SREBP-2, the membrane protein (100|ag) and total protein (50|ig) aliquots 
were size-fractionated on 8% SDS-PAGE at 120V for two hours. The whole 
procedures were described as above except for 1:300 anti-SREBP-2 antibody (Santa 
Cruz Biotechnology, Inc., USA) was used as primary antibody. Both precursor and 
mature form of SREBP-2 were identified on the same membrane. 
2.3.5 Probe production for LDL-receptor 
2.3.5.1 Extraction of total RNA 
RNA was isolated from frozen liver using TRIzol reagent (Invitrogen, Carlsbad, 
CA, USA). Briefly, lOOmg of liver was homogenized in ImL of TRIzol reagent. After 
that, 0,2mL of chloroform was added and centrifuged at 12,000 rpm for 15 minutes at 
4�C. The supernatant was transferred to a clean eppendorf containing 0.5mL 
isopropanol. The mixture was centrifuged again at 12,000 rpm for 15 minutes at 4�C. 
The supernatant was removed and 70% ethanol was added to wash the pellet. It was 
then centrifuged at 8,000 rpm for 10 minutes at 4°C. The supernatant was removed 
and the pellet was dissolved with formamide. The RNA concentration was 
determinutesed from the absorbance at 260nm and all samples had an 260/280 run 
absorbance ratio of about 2.0.The extracted RNA was stored at -7Q�C until further use. 
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2.3.5.2 Reverse-transcription reaction of total RNA 
The reverse-transcription was carried out by Super Script™ II RT (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer's protocol. Briefly, l | ig of total 
RNA was added to reaction mixture contained 01igo(dT)12-18 (500|Lig/ml), l|il dNTP 
Mix (lOmM each) Ijol and the final volume was adjusted to I2\il by autoclaved 
double distilled water. The reaction mixture was heated to 65�C for 5 minutes and 
chilled on ice quickly. After that, First-Strand Buffer (Ix) and DTT (0.1 M) was added 
to the mixture and the mixture was heated again at 42�C for 2 minutes. After heating, 
1^1 (200 units) of SuperScript™ II RT was added and incubated at 4TC for 50 
minutes. Finally, the reaction was inactivated by heating at 70°C for 15 minutes. The 
cDNA was used as a template for amplification in PGR. 
2.3.5.3 Polymerase chain reaction (PCR) of LDL- receptor fragment from cDNA 
template 
The LDL-receptor sequence was amplified using Taq DNA polymerase (Gibcol 
BRL, Grand Island, NY, USA) from the cDNA template. Forward primer (5' - att ttg 
gag gat gag aag cag — 3') and reverse primer (5' — cag ggc ggg gag gtg tga gaa — 3') 
(Life Technology, USA) were designed (size: 931 bp) based on the sequence 
published in GeneBank database (assession no.: XI3722). 
The PCR reaction mixture contained l|il first cDNA, Ix PCR buffer, l.SmM 
MgCli, 0.2mM of each dATP, dCTP, dGTP, dTTP, 1.0|iM primers and lU Taq DNA 
polymerase (Gibcol BRL, Grand Island, NY, USA), the final volume was adjusted to 
50|il by autoclaved double distilled water. Reaction mixtures were heated to 94°C for 
5 minutes to denature the template completely before addition of Taq polymerase. 
PCR reactions were performed in Peltier Thermal Cycler PTC200 (MJ Research Inc., 
Waltham, Massachusetts, USA) for 25 cycles and the condition was 94°C for 1 
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minutes, 60°C for 1 minutes and 72°C for 2 minutes. After completing 25 cycles, the 
reaction mixture was heated at 72°C for 10 minutes and was kept at 4�C until use. 
2.3.5.4 Separation and purification of PGR products 
PGR products were separated on 1% agarose gel (Gibcol BRL, Grand Island, NY, 
USA) containing ethidium bromide in TAE buffer (40mM Tris, 20mM Sodium 
Acetate, ImM EDTA, pH 7.4) by electrophoresis. PGR products were visualized 
under UV light and bands of correct size, determined by comparison with DNA 
molecular weight markers (Gibcol BRL, Grand Island, NY, USA), were cut out by 
ordinary razor blade. 
DNA excised from the agarose gel was purified by GeneClean II (Biol01, La 
Jolla, CA, USA) according to the manufacturer's protocol. Briefly, 1 ml of sodium 
iodide solution was added to the agarose gel with DNA band and incubated at 55�C 
until the gel was dissolved completely. 5|il of GLASSMILK suspension from the kit 
was then added to the above mixture solution. The reaction mixture was kept on ice 
with constant agitation for about 20 minutes to allow DNA bind to the GLASSMILK 
beads. The reaction was terminated by brief centrifugation to spin-down the beads. 
The supernatant was then discarded and the pellet was washed three times with New 
Wash Solution supplied together with the kit. The washed pellet was re-suspended in 
20|il autoclaved double distilled water and was incubated at 55°C for 10 minutes. 
Finally, the GLASSMILK beads were spun down for 1 minute and the supernatant 
containing the eluted DNA was collected and stored at -20°C until use. 
2.3.5.5 Polishing of purified PCR products 
PGR fragment were polished in order to create the blunt ends needed to improve 
overall cloning efficiency. The procedures were carried out according to the 
PCR-Script™ Cloning Kit (Strategene, La Jolla, CA, USA) Briefly, ImM dNTP mix, 
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l)il Ix polishing buffer and 0.5U of cloned pfu DNA polymerase were added orderly 
to the purified PGR products and the final volume was adjusted to lOjil by autoclaved 
double distilled water. The reaction mixture was incubated for 30 minutes at 72�C. 
The polished PGR products were stored at -20°C until further use. 
2.3.5.6 Ligation of PGR products and pPCR-script Amp SK(+) cloning vector 
The PGR products were inserted into the cloning vector by PCR-Script™ 
Cloning Kit (Strategene, La Jolla, CA, USA) according to the manufacturer's protocol. 
Briefly, ligation mixture containing lOng pPCR-Script Amp SK(+) cloning vector, Ix 
PCR-Script reaction buffer, 0.5mM rATP, polished PGR products, 5U Srf I restriction 
enzyme, 4U T4 DNA ligase were mixed and the final volume was adjusted to 10|il by 
autoclaved double distilled water. The ligation reaction was carried out for one hour at 
room temperature and stopped by heating the reaction mixture for 10 minutes. The 
ligation reactions were stored on ice before transformed into DH5a competent cell. 
2.3.5.7 Transformation 
Transformation was performed according to the manufacturer's protocol. Briefly, 
3|il of ligation mixture was added to lOOjil DH5a competent cell. The mixture was 
swirled gently and incubated on ice for 30 minutes for the plasmid DNA attached to 
the cell surface of the competent cells. The mixture was subjected to heat shock at 42 
�C for 40 seconds to allow the plasmid enter the host cell and then chilled on ice 
immediately for 2 minutes. Thereafter, the competent cell and plasmid mixture was 
incubated in 1ml LB medium at 37°C for 1 hour with shaking at 225-250 rpm to 
allow cells grow. The LB medium was subsequently centrifuged for 5 minutes to 
pellet the cells. The cell pellet was dissolved in lOOjil LB medium. 40|il of 2% X-gal 
and 4|il of IPTG (200mg/ml) were added to the resuspended cells in order to allow 
blue-white color screening. The final transformation mixture was spread evenly on a 
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pre-warmed agar plate with 50|ig/ml amplicillin. The plates were incubated overnight 
at 37°C to allow growth of colonies. 
2.3.5.8 Preparing glycerol stocks containing the bacterial clones 
Several white colonies were picked from each of the overnight-cultured agar 
plates by sterilized pipette tips. Each colony was grown in 10ml Amp-LB medium at 
37�C overnight with shaking at 250 rpm to allow the growth of bacteria containing 
the plasmids. After that, 500|il of the overnight-cultured bacterial clone was pipetted 
out and transferred to a sterile 1.5ml tube containing equal volume sterile 80% 
glycerol (Sigma, St Louis, MO, USA). The mixture was mixed thoroughly and kept at 
-70�C for long-term storage. 
2.3.5.9 Plasmid DNA preparation 
The plasmid DNA was extracted from the overnight-cultured Amp-LB medium 
containing the bacterial clones by Wizard ® Plus SV Minipreps DNA Purification 
Sysrem (Promega, Madison, Wis., USA) according to the manufacturer's protocol. 
Briefly, medium containing the bacterial clones were pelleted by centrifugation for 15 
minutes at 3,500 rpm. The supernatant was discarded and the pellet was resuspended 
with 250|il cell resuspension solution. 250|il cell lysis solution and lOfil alkaline 
protease solution were added to each sample and mixed. The reaction mixture was 
incubated at room temperature for 5 minutes. After that, 350|il neutralization solution 
was added and the reaction mixture was centrifuge at 12,000 rpm for 10 minutes at 
room temperature. The cleared lysate was decant into spin column and centrifuged at 
12,000 rpm for 1 minute at room temperature and the flowthrough was discarded. 
After addition of 750|il wash solution, the reaction mixture was centrifuged at 12,000 
rpm for 1 minute and the flowthrough was discarded. The previous step was repeated 
with 250|al wash solution. 100|j1 nuclease-free water was added to the spin column 
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and the whole set up was centrifuged at 12,000 rpm for 1 minute. The eluted water 
containing plasmid DNA was kept in eppendorf and stored at -20�C until use. 
2.3.5.10 Clones confirmation by restriction enzyme digestion 
To check whether the clones contained the LDL-receptor fragment, the DNA 
plasmid was digested by restriction enzymes. Insert in the cloning vector was released 
by cutting the plasmid with restriction enzymes, Hinc II (Gibcol BRL, Grand Island, 
NY, USA). Restriction enzyme reaction mixture contained plasmid DNA, lOU of 
enzyme and suitable buffer. The reaction was carried out at 37°C for 1 hour. The 
reaction mixture was then separated by electrophoresis on the agarose gel and the size 
of the released fragments was compared with the DNA molecular markers. The uncut 
plasmid DNA was also loaded on the gel as control. A fragment, which was about 
300bp was released after the enzyme digestion. Clones that could generate fragments 
with correct size were selected out and performed automatic sequencing for further 
confirmation. 
2.3.5.11 Clones confirmation by automatic sequencing 
Automatic sequencing was used to further check whether the clones contained 
LDL-receptor fragment. This was performed using ABI-PRISM™ DNA sequencing 
kit (Perkin Elmer, Foster City, California, USA) in an ABI-PRISM™ DNA 
sequencing system (Advanced ABI 310 Genetic Analyzer, Perkin Elmer, Foster City, 
California, USA) according to the manufacturer's protocol. 
The sequencing mixture contained 50ng plasmid DNA, 3.2pmole of primer 
(either upstream or downstream), 8|il Terminator Ready Reaction Mix (Perkin Elmer, 
Foster City, California, USA) and the final volume was adjusted to 20|il by 
autoclaved double distilled water. Reaction was carried out in a DNA thermal cycler 
for 25 cycles under the following condition: 96�C for 1 minute, Tm of the primer 
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used for 1 minute and 60。C for 4 minutes. Upon completion, the reaction mixture 
was precipitated by 2 volumes of absolute ethanol and 0.1 volume of 0.5M sodium 
acetate at pH 5.4 at -70°C for 1 hour and pelleted by centrifugation at 12,000 rpm for 
30 minutes at 4 � C . The pellet was washed with 70% ethanol and ethanol was 
evaporated. After the last trace of ethanol was evaporated, the pellet was dissolved in 
20)11 autoclaved doubled distilled water. Equal volume of Terminator Ready Reaction 
buffer supplied with the sequencing kit was added to the dissolved DNA. The mixture 
was mixed and incubated at 95°C for 3 minutes. Immediately after that, the mixture 
was chilled for 2 minutes. Finally, the content was analyzed using an automated DNA 
sequencer. 
The sequencing data obtained were submitted to the BLAST sequence similarity 
search (NCBI, National Center for Biotechnology Information) to confirm whether 
the clone contained target sequence. A typical profile of automatic sequencing was 
showed in Figure 2.1. 
2.3.5.12 Linearization of the plasmid DNA 
The plasmid DNA template that contained the LDL-receptor fragment was linearized 
by restriction enzyme, Hind III, which had one cutting site between the T7 promoter 
region and the 5' end of the insert. The reaction mixture contained more than l|ig of 
plasmid DNA, Ix appropriate buffer for the restriction enzyme, lU of Hind III 
(Gibcol BRL, Grand Island, NY, USA) and the final volume was adjusted to 20^1 by 
autoclaved double distilled water. After the reaction was completed, 0.1 volume of the 
digested mixture was pipetted out and loaded on 0.1% agarose gel to ensure that all 
plasmids had been linearlized. The remaining linearized plasmid DNA was extracted 
once by phenol/chloroform and precipitated by ethanol precipitation. The reaction 
mixture was precipitated by 2 volumes of absolute ethanol and 0.1 volume of 0.5M 
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Figure 2.1. Atypical profile of automatic sequencing for the confirmation of clones in 
DNA/RNA probe production. 
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s o d i u m a c e t a t e at p H 5 . 4 at - 7 0 � C f o r o n e h o u r a n d p e l l e t e d by 
centrifugation at 12,000 rpm for 30 minutes at 4°C and washed in 70% ethanol. After 
the evaporation of the last trace of ethanol, the pellet was dissolved in 20|il autoclaved 
double distilled water. 
2.3.5.13 DIG-labeling o fRNA probe 
DIG RNA labeling kit (Roche, Mannheim, Germany) was used for the 
production of DIG-labeled RNA probe. DIG-RNA labeling reaction was performed 
according to the manufacturer's protocol. Briefly, l|ig of linearized and purified 
LDL-receptor template was added to a sterile, RNase-free microfuge tube containing 
2[i\ of lOx NTP labeling mixture, l|il of RNase inhibitor, 2|il of lOx transcription 
buffer and 2\i\ of T3 RNA polymerase (Roche, Mannheim, Germany). The final 
volume was filled up to 20|il by adding DEPC-treated water. The reaction mixture 
was mixed gently and centrifuged briefly to collect all the mixture at the bottom of the 
tube. It was then incubated at 37�C for 2 hours. To remove DNA template in the 
reaction mixture, 2\x\ of DNase I was added and incubated at 37�C for additional 15 
minutes. 2jil of 0.2M EDTA was then added to stop the transcription reaction. To 
purify the DIG-labeled RNA probe from the reagents, 0.1 volume of 4M LiCl, 3 
volume of cold absolute ethanol was added to the reaction mixture. It was gently 
mixed and incubated at -70°C for 1 hour. After incubation, the tube was centrifuged 
at 13,000 rpm for 30 minutes at 4�C and the RNA pellet was washed by 70% ethanol. 
The DIG-labeled LDL-receptor probe was then dissolved in 100|il DEPC-treated 
water with l|il RNase-inhibitor. The probes were aliquoted into 10 microfuge tubes 
each containing 10|il solution and stored at -70°C until use. 
2.3.5.14 Testing of DIG-labeled probe 
Before performing Northern hybridization, it was essential to test whether the 
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RNA probe had been properly DIG-labeled. This was done according to the 
manufacturer's protocol. Briefly, 2|il of newly synthesized DIG-RNA probe was 
spotted on a small piece of nitrocellulose membrane. RNA probe was fixed on the 
membrane by UV cross-linking. The membrane was washed briefly in maleic acid 
buffer (O.IM Maleic acid, 0.15M NaCl, pH 7.5) for 5 minutes at room temperature, 
followed by the incubation of membrane in Ix blocking solution (Roche, Mannheim, 
Germany) for 15 minutes. Anti-DIG antibody diluted with Ix blocking solution 
(1:1500) was added to the membrane and incubated for 15 minutes. The membrane 
was washed in maleic acid buffer for 3 times, 5 minutes each. Then, the membrane 
was washed in maleic acid buffer with 0.05% Tween-20 for 3 minutes. To detect the 
desired spots on the membrane, colour-substrate solution (NBT/BCIP, Roche, 
Mannheim, Germany) dissolved in 10ml of DEPC-treated water was added and 
incubated at room temperature until colour was observed. Dark purple spot appeared 
on the membrane represented that the RNA was labeled and could be used for 
Northern hybridization. 
2.3.6 Probe production for HMG-CoA reductase 
The expressed sequence-tagged (EST) clone for HMG-CoA reductase (Image ID: 
1 771 090) was purchased from ATCC (VA, USA). Several white colonies were 
picked from each of the agar plates supplied from ATCC by sterilized pipette tips. 
Each colony was grown in 10ml Amp-LB medium at 37°C overnight with shaking at 
250 rpm to allow the growth of bacteria containing the plasmids. After that, 500|il of 
the overnight-cultured bacterial clone was pipetted out and transferred to a sterile 
1.5ml tube containing equal volume sterile 80% glycerol (Sigma, St Louis, MO, 
USA). The mixture was mixed thoroughly and kept at -70。C for long-term storage. 
Plasmid DNA was extracted with the method described in 2.3.5.9. Restriction 
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enzyme digestion and automatic sequencing described in 2.3.5.10 and 2.3.5.11 were 
performed to confirm the plasmid DNA contained the target gene. The plasmid was 
linearized according to the method described above except Pvu II, which had one 
cutting site upstream of the T7 promoter region and another cutting site on the 
downstream of T3 promoter region, was used. The DIG-labeled RNA probe was 
produced and tested with the method described in 2.3.5.14. 
2.3.7 Probe production for GAPDH 
The GAPDH sequence was amplified using Taq DNA polymerase (Gibcol BRL, 
Grand Island, NY, USA) from the cDNA template. Forward primer (5'- acc aca gtc 
cat gcc ate ac - 3') and reverse primer (5, - tcc acc acc ctg ttg ctg ta - 3') (Life 
Technology, USA) were designed (size: 452bp) based on the sequence published in 
GeneBank database (assession no.: X02231). PGR reactions were performed in Peltier 
Thermal Cycler PTC200 (MJ Research Inc., Waltham, Massachusetts, USA) for 25 
cycles and the condition was 94�C for 1 minutes, 60�C for 1 minutes and 72�C for 2 
minutes. After completing 25 cycles, the reaction mixture was heated at 72°C for 10 
minutes and was kept at 4�C until use. The PGR product was separated and purified 
according the method described above. 
DIG High Prime DNA Labeling and Detection Starter Kit II (Roche, Mannheim, 
Germany) was used for the production of DIG-labeled DNA probe. DIG-DNA 
labeling reaction was performed according to the manufacturer's protocol. Briefly, 
l|xg of GAPDH template DNA was added to a sterile, RNase-free microfuge tube and 
the final volume was filled up to 16|al by addition of autoclaved, double distilled 
water. The reaction mixture was heated to 95�C for 10 minutes and chilled in ice bath 
quickly to denature the DNA template. The labeling of the DNA template was carried 
out by addition of DIG-High Prime (Roche, Mannheim, Germany) and incubated at 
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37°C for 1 hour. After incubation, the reaction was stopped by heating the mixture to 
65°C for 10 minutes. The probe was stored at -70°C until further use. The probe was 
tested with the method described in 2.3.5.14. 
2.3.8 Northern blot 
Total RNA was extracted according to the method described above. RNA 
samples were applied (25jag/lane) to a 1.5% agarose gel containing 0.41M 
formaldehyde and fractionated by horizontal gel electrophoresis at 55V for 4 hours. 
After electrophoretic fractionation, RNA was transferred overnight to a positively 
charged nylon membrane by capillary blotting and the membrane was fixed with UV 
crosslinker (Strategene, La Jolla, CA, USA). 
Pre-hybridization was performed at 50 °C for 45 minutes in 25ml of 
pre-hybridization solution (DIG Easy Hub, Roche, Mannheim, Germany). 
Hybridization was at 50°C overnight in 25ml of pre-hybridization solution containing 
oligonucleotide probe (lOOng/ml). In the case of the probe specific for LDL-receptor 
gene, pre-hybridization and hybridization were set at 55 °C • The following 
post-hybridization washes were performed: twice for 5 minutes in 2xSSC/0.1% SDS 
at room temperature, twice for 15 minutes in O.lxSSC/0.1% SDS at 60°C for 
LDL-receptor probe and 55°C for HMG-CoA reductase/GAPDH probe. 
The membranes were then rinsed briefly with washing buffer (O.IM maleic acid, 
0.15M NaCl and 0.3% Tween-20, pH 7.5). They were blocked by incubation for 30 
minutes at room temperature with blocking solution (Roche, Mannheim, Germany). 
After that, the membrane was incubated in Ix blocking solution with a polyclonal 
antibody against 1:10,000 digoxigenin (Fab fragment, Roche, Mannheim, Germany). 
After being washed twice for 15 minutes with washing buffer, the membranes 
were rinsed for 5 minutes with detection buffer (O.IM Tris-HCl and O.IM NaCl, pH 
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9.5) and immersed for 5 minutes in CDP-Star solution (Roche, Mannheim, Germany). 
Membranes were exposed to Fuji medical x-ray (SUPER RX) film for 15 to 60 
minutes at room temperature. 
Signals were scanned and quantified using the Sigma Scan software program 
(Jandel Scientific, San Rafael, CA, USA) and the level of mRNA for LDL-receptor 
and HMG-CoA reductase were estimated. The values were normalized to the 
corresponding amount of GAPDH mRNA. 
2.3.9 Determination of hepatic cholesterol 
Total lipids were extracted from 300mg of sample with addition of Img 
stimastanol as an internal standard, using 15ml chloroform-methanol (2:1, v/v) and 3 
ml saline. The chloroform-methanol phase was removed after centrifugation and dried 
down under a gentle nitrogen steam. After an hour mild hydrolysis with 5ml NaOH in 
90% ethanol at 90�C, 1ml of water and 6ml of cyclohexane were added for cholesterol 
extraction. The cyclohexane phase was removed after centrifugation and evaporated 
to dryness under a gentle nitrogen steam. Cholesterol extract was converted to their 
trimethyl-silyl (TMS)-ether derivatives by a commercial TMS reagent (dry 
pyridine-hexamethyldisilazane-trichlorosilane, 9:3:1 v/v/v, sil-A reagent; Sigma). 
After the incubation at 60°C for an hour, the mixture was dried under nitrogen. The 
TMS-ether derivative was dissolved in 600|il of hexane, and after centrifugation, the 
hexane phase was transferred to a vial for gas-liquid chromatograph (GLC) analysis. 
Analysis of the cholesterol TMS-ether derivative was performed in a fused silica 
capillary column (SAC™.5, 30 m ‘ 0.25mm, i.d.; Supelco, Inc., Bellefonte, PA, USA) 
in a Shimadzu GC-14B GLC equipped with a flame-ionization detector (Shimadzu, 
Tokyo, Japan). The column temperature was programmed at 285°C and maintained 
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for 20min. Helium was used as carrier gas at a head pressure of 22 psi. A typical 
profile of hepatic cholesterol and internal standard was showed in Figure 2.2. 
2.3.10 Statistics 
Results were presented as means士standard error of means (S.E.M.) of samples 
from 5 rats or hamsters. The statistical significance of differences between groups was 
assessed by one-way analysis of variance (ANOVA) followed by Student's "test or 
Turkey's multiple comparison test, using Prism® (Graphpad software, Inc., CA, 
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Figure 2.2. Gas liquid chromatographic profile of hepatic cholesterol and internal 
standard (stigmastanol). 
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2.4.1 Growth and food intake 
Table 2.1 showed the changes in body weight and food intake of rats and 
hamsters after one month feeding, on various cholesterol diets. The initial and final 
body weight and daily food intake of rat in various groups showed no significant 
difference when compared with the control. Similarly, initial body weight and daily 
food intake of hamster in various groups showed no significant difference when 
compared with the control group. However, the final body weight of 0.3% and 0.9% 
groups showed a significant decrease when compared with the control group 
(P<0.05). 
2.4.2 Effect of cholesterol supplements on serum cholesterol 
Figure 2.1 showed the changes in serum total cholesterol (TC) in rats and 
hamsters maintained on various cholesterol diets for one month. The serum total 
cholesterol level of hamsters was much higher than that of the corresponding rat 
groups (PO.OOl). The serum TC of rats increased to 142.4 士 35.7mg/dl, in 0.9% diet 
group. In contrast, the serum TC level increased to 247.2 士 29.7mg/dl in hamsters 
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Figure 2.1. Changes in serum cholesterol level in rats and hamsters maintained on the 
control diet (0.0%), 0.3%, 0.6% and 0.9% cholesterol diet for one month. Data are 
means士S.E.M, n=5. * P<0.05 when compared with the control; # P<0.001 when 
compared with the rats at the same cholesterol level. 
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2.4.3 Effect of cholesterol supplements on liver cholesterol content 
Figure 2.2 showed the liver cholesterol content of rat and hamster in various 
groups. The liver cholesterol content of rat had shown a stepwise increase from 7.6 士 
3.0mg/g to 23.5 士 1.7mg/g with increasing level of chemical cholesterol supplement 
in diet. The liver cholesterol content of hamsters, interestingly, increased sharply from 
5.5 士 0.5mg/g for 0.0% group to 33.9 士 3.9mg/g for 0.3% group. However, the liver 
cholesterol content of hamsters drop to 29�6 士 5.7mg/g and 26.9 士 1.9mg/g for the 
0.6% and 0.9% group respectively. 
2.4.4 Stimulatory effect of high cholesterol diet on nSREBP-2, LDL-receptor and 
HMG-CoA reductase in rats 
Figure 2.3 showed immunoblots and group results of the nSREBP-2 in livers of 
rats feeding varying amount of cholesterol for one month. The amounts of the 
nSREBP-2 showed an increase in a concentration-dependent manner. Statistically 
significant increase was recorded for 0.6% and 0.9% cholesterol group where 
nSREBP-2 had increased by 115% (P<0.05) and 252% (P<0.001), respectively. 
The gene of LDL-receptor was up-regulated by the transcription factor, 
nSREBP-2. Western blot analysis of LDL-receptor in membrane extracts and its 
group data were shown on Figure 2.4. The general expression pattern of the 
LDL-receptor was similar to that of nSREBP-2. Statistically significant increase was 
recorded for 0.6% and 0.9% cholesterol group where LDL-receptor had increased by 
167% (P<0.05) and 274% (P<0.001), respectively. 
4 5 
40-1 *** 
一 T * * * 。 … R a t 
0 1 
^ *** H a m s t e r 
P - z . . 口 
1 
0-1 1 1 1 
0 . 0 % 0.3 % 0.6 o/o 0 . 9 % 
Diet group 
Figure 2.2. Changes in liver cholesterol level in rats and hamsters maintained on the 
control diet (0.0%), 0.3%, 0.6% and 0.9% cholesterol diet. Data are means士S.E.M., 
n=5. ** P<0.01 and *** P<0.001 when compared with the control. 
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Figure 2.3. Representative Western blot and group data depicting nSREBP-2 
abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 
and 0.9% cholesterol diet. Data are mean士S.E.M., n=5. * P < 0.05, *** P<0.001 when 
compared with the control. 
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Figure 2.4. Representative Western blot and group data depicting LDL-receptor 
abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 
and 0.9% cholesterol diet. Data are mean士S.E.M, n=5. * P < 0.05, *** < 0.001 when 
compared with the control. 
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HMG-CoA reductase is another gene that can be up-regulated by nSREBP-2, 
which also acts as transcription factor. Western blot analysis of HMG-CoA reductase 
and its group data were shown in Figure 2.5. No change in the protein expression 
level of HMG-CoA reductase in rat liver was observed when dietary cholesterol was 
increased. 
2.4.5 Effect of high cholesterol diet on nSREBP-2, LDL-receptor and HMG-CoA 
reductase in hamsters 
Figure 2.6 showed immunoblots and group results of the nSREBP-2 in liver of 
hamsters fed various cholesterol diets. The amounts of nSREBP-2 showed no or little 
changes in response to dietary cholesterol when compared with the control diet. In 
fact, 0.3% to 0.9% diet groups had nSREBP-2 dropped slightly. 
Western blot analysis of LDL-receptor and its group data are shown as Figure 2.7. 
It should be noted that while nSREBP-2, the transcription factor of LDL-receptor 
gene, showed slight decrease in its expression level in hamsters fed various high 
cholesterol diets. However, the LDL-receptor expression level did not drop according 
to the level of nSREBP-2. Changes in LDL-receptor expression among the groups 
were statistically insignificant when compared with the control. 
Western blot analysis of HMGR and its group data are shown in Figure 2.8. No 
statistically significant change was observed in expression level of HMG-CoA 
reductase for different groups fed various cholesterol diets. 
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Figure 2.5. Representative Western blot and group data depicting HMG-CoA 
reductase abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 
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Figure 2.6. Representative Western blot and group data depicting nSREBP-2 
abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 0.3%, 
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Figure 2.7. Representative Western blot and group data depicting LDL-receptor 
abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 0.3%, 
0.6 and 0.9% cholesterol diet. Data are mean士S.E�M., n=5. 
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Figure 2,8. Representative Western blot and group data depicting HMG-CoA 
reductase abundance in the liver of Golden Syrian hamsters fed the control diet 
(0.0%), 0.3%, 0.6 and 0.9% cholesterol diet. Data are mean士S.E.M., n-5. 
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2.4.6 The regulation of LDL-receptor and HMG-CoA reductase existed at 
transcriptional level 
The mRNA expression level of LDL-receptor and HMG-CoA reductase were 
measured in both rats and hamsters fed various cholesterol, using GAPDH to 
normalize the uneven loading of samples. In Figure 2.9, the mRNA expression level 
of LDL-receptor in rats showed a similar pattern as that observed in protein 
expression. Statistically significant increments were observed for 0.6% group (175 士 
20 %, P < 0.05) and 0.9% group (279 士 10 o/o, P < 0.05), compared with the control. 
However, no statistically increment for HMG-CoA reductase mRNA expression, 
among all the rat groups was observed (Figure 2.10). For hamsters, no statistical 
significant change was observed in mRNA of LDL-receptor and HMG-CoA reductase, 
which was consistent with the protein expression pattern, (Figure 2.11 & 2.12). 
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Figure 2.9. Representative Northern blot and group data depicting LDL-receptor 
mRNA abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 
O.30/0, 0.6 and 0.9% cholesterol diet. Data are mean士S.E.M., n=5.* P<0.05 when 
compared with control. 
55 
1.5-1 
1 1 . � - 门 n _ • 
L X 
0.0 % 0.3 % 0.6 % 0.9 % 
Diet group 
了 暴 ^ m m 
力、,Z 、 、 ^ ； I 山丨 挪X»SS5SW\VJ»\�>W«<•”一V ‘ � � � � � � � � � � ~ * ^ ~ ^ � � � � � � � � � � � � � � 
Figure 2.10. Representative Northern blot and group data depicting HMG-CoA 
reductase mRNA abundance in the liver of Sprague-Dawley rats fed the control diet 
(0.0%), 0.3%, 0.6 and 0.9% cholesterol diet. Data are mean士S.E.M., n=5. 
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Figure 2.11. Representative Northern blot and group data depicting LDL-receptor 
mRNA abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 
0.3%, 0.6 and 0.9% cholesterol diet. Data are mean士S.E.M., n二5. 
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Figure 2.12. Representative Northern blot and group data depicting HMG-CoA 
reductase mRNA abundance in the liver of Golden Syrian hamsters fed the control 
diet (0.0%), 0.3%, 0.6 and 0.9% cholesterol diet. Data are mean士S.E.M., n=5. 
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2.5 Discussion 
The present study clearly demonstrated that rats and hamsters responded 
differently to the dietary cholesterol. Rats did not necessarily have a sharp increase in 
serum cholesterol level in response to a higher cholesterol diet and were regarded as a 
"hypo-responsive" model. In contrast, hamster had a sharp increase in serum 
cholesterol level in response to increasing dietary cholesterol and thus was regarded 
as a "hyper-responsive" model in this experiment. 
The present results showed that LDL-receptor in rats was up-regulated while that 
in hamsters was insensitive to dietary cholesterol. Up-regulation of LDL-receptor in 
rats would lead to efficient uptake of LDL-C by the liver and hence the level of serum 
cholesterol had not risen sharply in response to a high cholesterol diet. In this regard, 
the cholesterol content in rat liver had demonstrated a consistent result. With the 
increasing cholesterol levels in diet, the more liver cholesterol was detected. The 
present result was in agreement with that of Roach et al. (1993), who demonstrated 
that dietary cholesterol increased the mass of hepatic LDL-receptor in young rats. 
However, the LDL-receptor was not increased in response to dietary cholesterol in old 
rats. Therefore, it was clear that age may be a factor influencing the expression of 
LDL-receptor. In our experiment, the rats and hamsters used were of the similar age, 
so that their difference in LDL-receptor expression was not due to their age. In 
another study, deliberate over-expression of LDL-receptors had been suggested to 
have anti-hypercholesterolemic effect on mice fed with a high cholesterol diet 
(Yokode et al., 1990). Hence, it was clear that up-regulation of LDL-receptor is one of 
the mechanisms to prevent sharp increase of plasma cholesterol in rats. 
Expression of HMG-CoA reductase is regulated mainly by a cellular cholesterol 
level. In response to a high cholesterol level in tissue, the expression level of 
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HMG-CoA reductase would decrease in order to maintain a constant level of 
cholesterol (Anderson et al., 1982). It had been suggested that the basal level 
expression of HMG-CoA reductase could be an indicator of tolerance to dietary 
cholesterol (Ness and Gertz, 2004a; 2004b; Ness and Chambers, 2000). The higher 
the basal expression of hepatic HMG-CoA reductase, the greater the "cholesterol 
buffering capacity" and the greater the resistance to dietary cholesterol. Interestingly, 
the rats have a high level of hepatic cholesterol biosynthesis and are known to be 
resistant to dietary cholesterol (Ness and Gertz, 2004b; Ness and Chambers, 2000; 
Spady and Dietschy, 1983). In contrast, hamsters exhibit a low level of HMG-CoA 
reductase and are very sensitive to dietary cholesterol (Spady et al., 1983). The present 
study did not found significant changes in hepatic HMG-CoA reductase of both rats 
and hamsters with the increasing cholesterol in the diet. Perhaps, 0.3% dietary 
cholesterol had repressed the expression of HMG-CoA reductase to its basal level. 
Further increment in dietary cholesterol (0.6% - 0.9%) could not further decrease the 
protein expression of HMG-CoA reductase. However, it should be noticed that rats 
have a greater basal expression of HMG-CoA reductase than hamsters. Even when 
both rats and hamsters had dropped their expression of HMG-CoA reductase to 
minimum level, the absolute reduction in cholesterol biosynthesis was actually greater 
in rats than hamsters (Spady et al., 1986). This was another mechanism accounted for 
the hypo-responsiveness of rats and hyper-responsiveness of hamsters to dietary 
cholesterol. 
The expression of LDL-receptor is controlled by nSREBP-2. We further 
investigated whether the different response in two animals were due to the expression 
of nSREBP-2 in rats and hamsters. The gene expression of LDL-receptor in both 
animals was consistent with that of nSREBP-2. In rats, the higher expression level of 
nSREBP-2 was associated with the higher level of LDL-receptor gene expression. In 
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hamsters, the unchanged expression level of nSREBP-2 in response to the increasing 
dietary cholesterol was linked with unchanged LDL-receptor gene expression. This 
observation was in agreement with the previous reports showed parallel expression of 
nSREBP-2 with LDL-receptor mRNA (Makar et a l , 1998; Mullen et al., 2004). 
Although both LDL-receptor and HMG-CoA reductase contained sterol 
regulatory element (SRE-1) which could be activated by nSREBP-2, the gene 
expression profile of LDL-receptor and HMG-CoA reductase was different in rats. 
The gene expression of HMG-CoA reductase was not up-regulated in response to 
increase in nSREBP-2. It was suggested that the difference may be due to higher 
similarity of LDL-receptor promoter sequence than that of HMG-CoA reductase with 
SREBP-2 (Vallett et al., 1996). In addition, activation of HMG-CoA reductase 
transcription may require coupling with other factors, such as nuclear factor 1 (NF-1) 
(Osborne, 1991), which was not up-regulated by dietary cholesterol. Hence, the cell 
could turn off the cholesterol synthesis by lowing HMG-CoA reductase expression 
but maintaining high level of LDL-receptor to allow efficient utilization of plasma 
cholesterol (Osborne, 1991). This was consistent with the current study that the 
LDL-receptor was up-regulated while HMG-CoA reductase was not changed in 
response to increase in nSREBP-2. This regulatory mechanism was important for rats 
to prevent sharp increase in plasma cholesterol in response to dietary cholesterol. 
The fundamental issue remains why nSREBP-2 was up-regulated in rats. It was 
demonstrated that the active (nuclear) form of SREBP-2, nSREBP-2, was produced 
from its precursor form (pSREBP-2) in response to the changing cholesterol level in 
the cell (Sakai et al., 1996). Low level of cellular cholesterol induces activation of 
SREBP-2, which up-regulates the expression of LDL-receptor gene, by binding to the 
SRE-1 region of the gene. On the other hand, when cellular cholesterol was high, 
SREBP-2 was deactivated and the expression of LDL-receptor was repressed (Hua et 
61 
al., 1993). However, the presnt results seemed to be contradictory to the above 
information. Despite the increasing dietary cholesterol had caused increase in hepatic 
cholesterol in rats, it still expressed higher level of nSREBP-2 to induce the 
expression of LDL-receptor at the transcriptional level. 
In the body, cholesterol homeostasis is controlled in the liver mainly by three 
factors: (i) uptake from blood (by LDL-receptor), (ii) biosynthesis (by HMG-CoA 
reductase) and (iii) elimination outside the body as bile acids (by CYP7A1). It is 
hypothesized that the up-regulation of nSREBP-2 in rats but not in hamsters due to its 
greater inhibition of biosynthesis and more efficient elimination of hepatic cholesterol. 
First, rats had a higher rate of cholesterol synthesis than hamsters. For the same extent 
of decrease of HMG-CoA reductase, the absolute reduction of cholesterol 
biosynthesis was greater in rats than hamsters (Spady et al., 1986). Second, rats may 
have a greater ability to eliminate cholesterol from the liver than hamsters. Both the 
drop in biosynthesis and efficient elimination of cholesterol in rats has created a net 
cholesterol efflux across the liver (Figure 2.13). In order to compensate for the drop in 
hepatic cholesterol, more SREBP-2 was converted from its precursor form to the 
active nuclear form. This up-regulated the transcription of LDL-receptor and 
promoted the uptake of plasma cholesterol from blood, as observed in the present 
results. In contrast, hamsters may not be efficient in the elimination of hepatic 
cholesterol. Cholesterol content in the liver remained stable and the SREBP-2 did not 
sense a need to up-regulate the nSREBP-2. As a result, the LDL-receptor was not 
up-regulated in hamsters with increasing dietary cholesterol. This hypothesis was 
supported by the results in chapter 3. In rats, the higher level of dietary cholesterol 
had stimulated a higher expression of CYP7A1 and excreted more fecal bile acids, 
indicating more efficient elimination of cholesterol. Conversely, hamsters are less 
efficient in cholesterol elimination as shown by unchanged CYP7A1 protein 
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expression and fecal bile acids in response to a higher dietary cholesterol. 
To summarize, rats were hypo-responsive to dietary cholesterol because they 
expressed higher level of LDL-receptor with the expression of HMG-CoA reductase 
being unchanged (Figure 2.14). This process was regulated at transcriptional level that 
was controlled by the active form of the transcription factor, SREBP-2. In contrast, 
hamsters were hyper-responsive to dietary cholesterol because they lack of response 
in LDL-receptor expression to high cholesterol diets (Figure 2.15). 
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Figure 2.13. Schematic diagram to show the mechanism for the up-regulation of 
SREBP-2 in rats in response to high dietary cholesterol. 
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Figure 2.14. Illustration of the hypo-responsive mechanism of rats in response to a 
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Figure 2.15. Illustration of the hyper-responsive mechanism of hamsters in response 
to a high dietary cholesterol. 
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CHAPTER 3 
Rats are hypo-responsive to dietary cholesterol due 
to efficient elimination of cholesterol 
3.1 Introduction 
In the body, the cholesterol elimination is mainly controlled by the liver, where 
excess cholesterol is converted to bile acids before they are eliminated. Figure 3.1 
illustrated the pathway of cholesterol elimination from cholesterol into bile acids. The 
majority of bile acids are biosynthesized by the classical pathway, which is controlled 
by a liver-specific rate-determining enzyme, CYP7A1 (Russell et al., 1992). It was 
found that up-regulation of LXR-a is associated with enhanced CYP7A1 expression 
in some animals, indicating LXR-a is a positive regulator of CYP7A1 (Gupta et al., 
2002; Chiang et al., 2001; Peet et al., 1998a). In turn, the activation of LXR-a is 
controlled by a substrate-mediated pathway, which requires binding of cholesterol 
(oxysterol) as ligands (Forman et al., 1997; Janowski et al., 1996). The activated 
LXR-a forms a heterodimer with retinoid X receptor (RXRs), which acts as a 
transcription factor binding to the LXR responsive element (LXRE) of CYP7A1 gene 








Hepatic cholesterol ^ Bile acids 
Figure 3.1. Illustration of the classical pathway involved in the conversion of 
cholesterol to bile acids. 
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3.2 Objective 
Cholesterol homeostasis is a balance of absorption and elimination. It was 
previously demonstrated that rats were hypo-responsive whereas hamsters were 
hyper-responsive to dietary cholesterol. This study was extended from chapter 2 to 
answer the question, whether the up-regulation of nSREBP-2 and LDL-receptor in 
rats was due to more efficient elimination of cholesterol than hamsters. In addition, 
the mechanism responsible for the different cholesterol elimination efficiency, if any, 
was determined. 
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3.3 Methods and materials 
3.3.1 Animals and diets 
Both Sprague-Dawley (SD) rats and Golden Syrian (GS) hamsters were divided 
into four groups (n=5 each group) and were maintained on one of four diets: 0.0%, 
0.3%, 0.6% and 0.9% cholesterol. The feeding conditions were previously described 
in Chapter 2. 
3.3.2 Western blot 
The total liver proteins and membrane proteins were obtained as previously 
described in Chapter 2. For the measurement of CYP7A1, the membrane protein 
(100|ig) was size-fractionated on 8% SDS-PAGE at 120V for two hours. After 
electrophoresis, proteins were transferred to a Hybond-ECL membrane (Amersham 
Life Science Inc., Arlington Heights, IL, USA). The membrane was incubated for one 
hour in blocking solution (Ix TBS, 0.1% Tween-20 and 5% nonfat milk) at room 
temperature and then overnight at 4°C in the same solution containing 1:300 
anti-CYP7Al antibody (Santa Cruz Biotechnology, Inc., California, USA). 
Membrane was washed once for 15 minutes then twice for five minutes in washing 
solution (Ix TBS and 0.1% Tween-20) prior to one hour incubation in blocking 
solution containing diluted (1:3000) horseradish peroxidase-linked rabbit anti-goat 
IgG (Zymed Laboratories Inc., South San Francisco, USA). The washes were 
repeated before the membranes were developed with chemiluminescent agents (ECL; 
Amersham Life Science) and subjected to autoradiography for one to five minutes. 
For LXR-a, the total protein (SO i^g) aliquots were size-fractionated on 8% 
SDS-PAGE at 120V for two hours. The whole procedures were as above described 
except for 1:300 anti-LXR-a antibody (Santa Cruz Biotechnology, Inc., USA) and 
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1:3000 donkey anti-rabbit IgG (Amersham Life Science Inc., Arlington Heights, IL, 
USA) was used as primary and secondary antibody, respectively. 
3.3.3 Probe production for CYP7A1 and LXR-a 
The procedure for RNA probe production was similar to HMG-CoA reductase as 
previously described in 2.3.6 except the expressed sequence-tagged (EST) clone for 
CYP7A1 (Image ID: 1 782 989) and LXR-a (Image ID: 2 695 317) was purchased 
from ATCC (VA, USA). 
3.3.4 Northern blot 
The Northern blot was carried out as previously described in 2.3.8. Hybridization 
and post-hybridization temperature were set at 50。C and 55�C, respectively. Signals 
were scanned and quantified using the Sigma Scan software program (Jandel 
Scientific, San Rafael, CA, USA) and the level of mRNA for CYP7A1 and LXR-a 
were estimated. The values were normalized to the corresponding amount of GAPDH 
mRNA. 
3.3.5 Determination of fecal neutral and acidic sterols 
The fecal neutral and acidic sterols were determined according to Czubayko et al. 
(1991) with some modifications. 
3.3.5.1 Separation of neutral and acidic sterols 
Fecal samples were first dried in a lyophilizer and then grinded. Stigmasterol 
(0.3mg/ml chloroform) and hyodeoxycholic acid (0.3mg/ml IN NaOH in 90% ethanol) 
were added to 300mg grinded fecal sample as internal standards for neutral and acidic 
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sterols, respectively. The samples were then subjected for alkaline hydrolysis in 8ml 
IN NaOH in 90% ethanol at 90。C for 1 hour followed by cooling down to room 
temperature. After that, 1 ml of distilled water and 8 ml of cyclohexane were added 
for extraction. After centrifugation, the upper cyclohexane phase and the lower 
aqueous phase were collected for neutral and acidic sterols analyses, respectively. 
3.3.5.2 Neutral sterols analysis 
The cyclohexane phase from the above process was evaporated to dryness under 
a gentle nitrogen stream. The neutral sterols were then converted to their TMS-ether 
derivatives by adding TMS-reagent (Sil-A reagent, Sigma) and heated at 60°C for 1 
hour. The mixture was then dried under nitrogen stream again and the 
TMS-derivatives of neutral sterols were dissolved in 400|al of hexane. After 
centrifugation, the hexane layer was transferred to a vial for GLC analysis. 
3.3.5.3 Acidic sterols analysis 
For the lower aqueous phase extracted from the above process, 1ml of ION 
NaOH was added to the lower aqueous phase and the mixture was then heated for 3 
hours at 120°C. After adding 3ml distilled water and cooling to the room temperature, 
the mixture were acidified to pH < 1 with 25% HCl. The acidic sterols were extracted 
twice with 7ml diethyl ether. The combined ether phase were evaporated under 
nitrogen stream. Methylation was performed by adding 2ml methanol, 2ml 
dimethoxypropane, and 40|il concentrated HCl. The samples were mixed thoroughly 
and allowed stand at room temperature for overnight. The acidic sterols were then 
dried under nitrogen stream and converted to their TMS-ether derivatives as described 
for neutral sterols. The dried samples were dissolved in 300|il hexane and then 
centrifuged. The hexane phase was transferred to a vial for GLC analysis. 
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3.3.5.4 GLC analysis of neutral and acidic sterols 
The GLC of fecal neutral and acidic sterols was carried out on a fused silica 
capillary column as described in 2.3.9. For neutral sterols, the column temperature 
was programmed at 285�C and maintained for 30 minutes. For the acidic sterols, the 
column temperature was programmed at 230-280°C at a rate of r c / m i n . Helium was 
used as the carrier gas at a head pressure of 22 psi in both neutral and acidic sterol 
GLC. Typical chromatogram of neutral and acidic sterols were shown in Figure 3.2 
and 3.3, respectively. 
3.3.6 Statistics 
Results were presented as means±standard error of means (S.E.M.) of samples 
from 5 rats or hamsters. The statistical significance of differences between groups was 
assessed by one-way analysis of variance (ANOVA) followed by Student's r-test or 
Turkey's multiple comparison test, using Prism® (Graphpad software, Inc., CA, 
USA). Differences between groups were considered significant when P<0.05. 
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Figure 3.2. Typical gas liquid chromatographic profile of fecal neutral sterols. 
Identification of peaks: 1, coprostanol; 2, coprostanone; 3, cholesterol; 4, 
dihydrocholesterol; 5. campersterol; 6, internal standard (stigmasterol). 
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Figure 3.3. Typical gas liquid chromatographic profile of fecal acidic sterols. 
Identification of peaks: 1, lithocholic acid; 2, deoxycholic acid; 3, chenodeoxycholic 




3.4.1 Effect of cholesterol supplements on fecal total neutral sterols 
Fecal neutral sterols represent the unabsorbed cholesterol in the intestine. Figure 
3.4 showed the fecal neutral sterol output by rats and hamsters from different diet 
groups. The fecal neutral sterols output by rats showed a sharp increase with the 
increasing of cholesterol content in the diet. The fecal neutral sterols output by rats 
constituted about 6 . 6 5 士 0.13mg/g for the control group ( 0 . 0 % ) , while it increased up 
to 29.66 士 3.02mg/g (P<0.05), 54.32士 5.55mg/g (P<0.01) and 129.50 士 0.82mg/g 
(PcO.OOl) for the 0.3%, 0.6% and 0.9% cholesterol groups, respectively. Although an 
increase across the diet groups with the increasing dietary cholesterol was also 
recorded in hamsters, the total fecal neutral sterols excretion was much less than that 
in the corresponding rat group. 
3.4.2 Effect of cholesterol supplements on fecal total bile acids 
Fecal total acidic sterols (bile acids) were measured to determine the amount of 
bile acids excreted in feces. Figure 3.5 showed the fecal bile acids output of rats and 
hamsters in different diet groups. The starting levels of fecal bile acids output for both 
animals were similar, which was about 0.6mg/g fecal bile acids for 0.0% cholesterol 
diet group. The fecal bile acids of rats increased to 2.09 士 0.26mg/g for 0.3% 
cholesterol diet group. After that, the fecal bile acids output raised sharply to 33.46 士 
4.14mg/g for 0.6% cholesterol diet group and reached the maximum of 37.53 士 
4.64mg/g for 0.9% cholesterol diet group. In contrast, the fecal bile acids output in 
hamsters remained at the level of below 1 mg/g among all the diet groups. 
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Figure 3.4. Fecal output of total neutral sterols in rats and hamsters maintained on the 
control diet (0.0%), 0.3% 0.6% and 0.9% cholesterol diet for one month. Data are 
means士S.E.M, n=5. * P<0.05, ** P<0.01 and *** P<0.001 when compared with the 
control. 
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Figure 3.5. Fecal output of total bile acids in rats and hamsters maintained on the 
control diet (0.0%), 0.3% 0.6% and 0.9% cholesterol diet for one month. Data are 
means士S.E.M, n=5. *** PO.OOl when compared with the control. 
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3.4.3 CYP7A1 protein on rats showed a concentration-dependent increase with 
response to dietary cholesterol while hamsters did not 
CYP7A1 catalyzes the rate-controlling reaction in the classic bile acid synthesis 
pathway. Figures 3.6 and 3.7 showed the immunoblots and group results of CYP7A1 
protein in rats and hamsters fed various high cholesterol diets. CYP7A1 protein 
expression increased with the increasing dietary cholesterol. Statistically significant 
increase was found with the groups treated with 0.9 % diet (2.56 士 0.45, P < 0.05). 
For hamster groups, however, no statistically significant change in CYP7A1 protein 
expression was observed among all diet groups. 
3.4.4 The regulation of CYP7A1 was at transcriptional level 
The mRNA expression level of CYP7A1 was also analyzed in both animals, 
using GAPDH to normalize the uneven loading of samples. Figure 3.8 showed the 
immunoblot and group results of the CYP7A1 mRNA expression in the liver of rats 
fed various cholesterol diets for a month, while Figure 3.9 for that of hamsters. It was 
observed that CYP7A1 mRNA expression of rats was up-regulated in accordance to 
the increasing amount of cholesterol in the diet. However, no significant change 
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Figure 3.6. Representative Western blot and group data depicting CYP7A1 
abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 
and 0.9% cholesterol diet for one month. Data are mean士S.E.M., n二5. * P<0.05 when 
compared with the control. 
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Figure 3.7. Representative Western blot and group data depicting CYP7A1 
abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 0.3%, 
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Figure 3.8. Representative Northern blot and group data depicting CYP7A1 mRNA 
abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 
and 0.9% cholesterol diet for one month. Data are mean士S.E.M., n=5. * P<0.05 when 
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Figure 3.9. Representative Northern blot and group data depicting CYP7A1 mRNA 
abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 0.3%, 
0.6 and 0.9% cholesterol diet for one month. Data are mean士S.E.M., n=5. 
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3.4.5 LXR-a demonstrated a parallel changes in its expression at both 
translational and transcriptional level 
LXR-a is the transcription factor of CYP7A1. Figure 3.10 showed the 
immunoblots and group results of LXR-a protein in rats fed various cholesterol diets. 
It was found that LXR-a protein expression increased with the increasing dietary 
cholesterol in rats. However, the LXR-a protein was not detectable in hamsters. 
The mRNA expression level of LXR-a in both rats and hamsters was determined, 
using GAPDH to normalize the uneven loading of samples. Figure 3.11 showed the 
photo and group results of the LXR-a mRNA expression in liver of rats fed various 
cholesterol diets for a month, while Figure 3.12 for that of hamsters. In rats, the 
mRNA expression of LXR-a was up-regulated in accordance to the increasing 
cholesterol in the diet though not statistically significant. In contrast, no changes were 
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Figure 3.10. Representative Western blot and group data depicting LXR-a abundance 
in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 and 0.9% 
cholesterol diet for one month. Data are mean士S.E.M., n=5. * P<0.05 when compared 
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Figure 3.11. Representative Northern blot and group data depicting LXR-a mRNA 
abundance in the liver of Sprague-Dawley rats fed the control diet (0.0%), 0.3%, 0.6 
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Figure 3.12. Representative Northern blot and group data depicting LXR-a mRNA 
abundance in the liver of Golden Syrian hamsters fed the control diet (0.0%), 0.3%, 
0.6 and 0.9% cholesterol diet for one month. Data are mean士S.E.M., n=5. 
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3.5 Discussion 
The present results clearly demonstrated that rats eliminated hepatic cholesterol 
more efficiently than hamsters. This was supported by two evidences. First, with 
increasing dietary cholesterol, rats excreted more fecal total neutral sterols and bile 
acids while hamsters only had minor increase in fecal total neutral sterols. Second, 
rats excreted more fecal total neutral sterols and bile acids than hamsters in the same 
diet group. The level of fecal total bile acids is closely related to the responsiveness to 
dietary cholesterol. A study conducted by Beynen et al. (1989) showed rabbits that 
were hypo-responsive to dietary cholesterol excreted more fecal bile acids than those 
hyper-responders. Therefore efficient elimination of cholesterol and bile acids was, at 
least partly, responsible for the hypo-responsive to dietary cholesterol in rats while the 
hyper-responsiveness in hamsters was due to inefficient removal of excess cholesterol 
in feces. 
There are two mechanisms responsible for the increased fecal bile acids 
excretion with increasing dietary cholesterol in rats: increased bile acids biosynthesis 
and inefficient bile acids reabsorption from the intestine via the enterohepatic 
circulation. The current study supported the view that increased bile acids 
biosynthesis was accounted for the increased fecal bile acids. This is because 
CYP7A1, the rate-determining enzyme which controls the conversion of hepatic 
cholesterol to bile acids (Russell 2003; Russell et a l , 1992), was up-regulated in 
response to higher dietary cholesterol in rats. However, the increased biosynthesis of 
bile acids could not be solely responsible for the increased fecal bile acids because 
enterohepatic circulation reabsorbed bile acids from intestine to the liver. If the 
enterohepatic circulation was efficient in rats, most of bile acids would be returned 
back to the liver but did not stay in the feces, as observed. It was suggested that 
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malabsorption of bile acids in rats responsible for the increased fecal bile acids 
(Horton et al., 1995; Bjorkhem et al., 1991). The observation of increased both fecal 
neutral sterols and bile acids in rats with increasing dietary cholesterol content 
suggested that the increased fecal neutral sterols might bind the bile acids in the 
intestine, hindering the reabsorption of bile acids to the liver. In fact, efficient removal 
of bile acids in feces further assists the up-regulation of CYP7A1 because bile acids 
inhibit the expression of CYP7A1 (Bjorkhem et al., 1991; Parks et al., 1991). Hence, 
it was suggested that both malaborption of bile acids and increased expression of 
CYP7A1, which were inter-related, were responsible for the increased fecal bile acids 
in rats. 
In contrast, unchanged fecal bile acids level was observed in hamsters in 
response to increasing dietary cholesterol. The finding that CYP7A1 protein 
expression was not increased in response to the higher dietary cholesterol content in 
hamsters was responsible for the differences between rats and hamsters. In fact, 
different effect of dietary cholesterol on CYP7A1 expression/activity was observed by 
Ando et al. (2005). Rats and mice showed a marked up-regulation whereas hamsters, 
monkeys, humans, guinea pigs, and rabbits did not respond or even repress CYP7A1 
expression with the increasing dietary cholesterol (Horton et al., 1995; Dueland et al., 
1993； Nguyen et al., 1999). The mechanism for the unchanged CYP7A1 protein 
expression in hamsters was supposed to be the opposite of rats, which had increased 
CYP7A1 protein expression in response to dietary cholesterol. As enterohepatic 
circulation was efficient in hamsters, more bile acids were reabsorbed back to the liver, 
which inhibit the expression of CYP7A1. Hence, both unchanged fecal bile acids and 
hepatic CYP7A1 protein expression were observed in hamsters with increasing 
dietary cholesterol content. 
This study further investigated whether any other factors involved in the 
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up-regulation of CYP7A1 in rats and unchanged expression of CYP7A1 in hamsters. 
It has been demonstrated in previous studies that LXR-a can up-regulate the 
expression of CYP7A1 (Chiang et aL, 2001; Gupta et al., 2002), hence, we looked 
into the effect of dietary cholesterol on LXR-a. The results showed that with 
increasing dietary cholesterol, up-regulation of LXR-a was observed in rats but not in 
hamsters. In addition, a parallel up-regulation of LXR-a and CYP7A1 at both 
mRNA/protein expression was observed in rats. Therefore, increase in CYP7A1 
protein and mRNA expression in response to the increasing dietary cholesterol in rats 
was controlled by LXR-a, at transcriptional level. The regulatory mechanism of 
LXR-a was demonstrated in one in vitro study showing that ligand bound LXR-a 
up-regulated CYP7A1 by binding to the LXRE in the CYP7A1 promoter region 
(Lehmann et al., 1997). Further evidence was obtained in the experiment with the 
analysis of LXR-a knock-out mice (LXR-a—,—)’ which could not up-regulate CYP7A1 
in response to cholesterol feeding (Peet et al., 1998b). On the other hand, LXR-a was 
not up-regulated in hamsters with increasing dietary cholesterol. Therefore, in 
addition to the malabsorption of bile acids, which inhibit the expression of CYP7A1, 
the up-regulation of CYP7A1 in rats was related to increased expression of LXR-a. 
On the other hand, the unchanged CYP7A1 expression in hamsters was due to the 
unchanged level of LXR-a in response to increasing dietary cholesterol and feedback 
regulation of bile acids. 
To summarize, rats were hypo-responsive to dietary cholesterol because they 
eliminated cholesterol efficiently. This was controlled by malabsorption and increased 
biosynthesis of bile acids. The biosynthesis of bile acids was increased because the 
expression of CYP7A1 was increased. The CYP7A1 expression was controlled at 
transcriptional level by its positive regulator, LXR-a, which increased in response to 
increasing dietary cholesterol. As a result, more hepatic cholesterol was converted to 
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bile acids in rats in response to dietary cholesterol (Figure 3.13). This pathway 
eliminated excess hepatic cholesterol and provided more space for further uptake of 
cholesterol from blood, via the LDL-receptor pathway, as demonstrated in Chapter 2. 
In contrast, hamsters were hyper-responsive to dietary cholesterol because their 
CYP7A1 and LXR-a expression did not respond significantly to any changes in 
dietary cholesterol content in the diet. As a result, excess cholesterol could not be 
removed from the liver and this hindered the uptake of cholesterol from blood, 
leading to a sharp increase in serum cholesterol level when dietary cholesterol was 
increased to 0.9% (Figure 3.14). 
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Rats are hypo-responsive to dietary cholesterol because: 
• Efficient elimination of cholesterol from the liver to fecal bile acids 
• The efflux of cholesterol in liver induced the expression of LDL-receptor 
(Chapter 2) and hence uptake more cholesterol from blood 
Figure 3.13. Illustration of the hypo-responsive mechanism of rats in response to a 
high dietary cholesterol. 
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Hamsters are hyper-responsive to dietary cholesterol because: 
• Inefficient elimination of cholesterol from the liver to fecal bile acids 
• The LDL-receptor was not up-regulated (Chapter 2) to uptake more cholesterol 
from blood 
Figure 3.14. Illustration of the hyper-responsive mechanism of hamsters in response 
to a high dietary cholesterol. 
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CHAPTER 4 
Mechanism for individual variation of 
serum cholesterol level in rats and hamsters 
fed a high cholesterol diet 
4.1 Introduction 
The previous two chapters investigated the effect of a high cholesterol diet on 
blood cholesterol level in rats and hamsters. Briefly, rats were hypo-responsive to a 
high cholesterol diet because the protein expression of LDL-receptor and CYP7A1 
was up-regulated in response to a high cholesterol level in the diet. As a result of the 
efficient elimination of cholesterol from the liver and increased uptake of cholesterol 
from blood, rats could therefore tolerate high dietary cholesterol. In contrast, hamsters 
were hyper-responsive to a high cholesterol diet. This was because the protein 
expression of LDL-receptor and CYP7A1 did not respond to the variation of 
cholesterol content in the diet. Hence, hamsters accumulated excess dietary 
cholesterol and led to a sharp increase in serum cholesterol in response to a high 
cholesterol diet. 
It is well-known that dietary cholesterol raises the average serum cholesterol 
concentration of a population (Ginsberg et al., 1995; Jones et al., 1994). For example, 
the study by Jones et al. (1994) has demonstrated that blood cholesterol is raised by 
4.1mg/dl per every lOOmg dietary cholesterol. However, not all individuals within the 
population are responsive in a same way to a high dietary cholesterol (Hegsted et al., 
1986; Glatz et al., 1993; Adrens et al., 1957; Herron et al., 2003). Instead, a great 
variability in response was found. Some individuals are hyper-responders to a high 
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dietary cholesterol and develop a sharp increase in blood cholesterol, while some are 
hypo-responders (Howell et al., 1997; Herron et al., 2003). McNamara et al. (2000) 
have estimated that about 15-25% of the population is sensitive to a high cholesterol 
diet. This has aroused our interest in investigating the underlying mechanism. 
9 5 
4.2 Objective 
This study was performed to determine individual variation in expression of 
CYP7A1, LDL-receptor, nSREBP-2, LXR-a and HMG-CoA reductase in response to 
a same amount of dietary cholesterol, using rats and hamsters as models. The 
information obtained would help explain why some are hyper- while some are 
hypo-responsive to dietary cholesterol within the same species. 
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4.3 Methods and materials 
4.3.1 Diet and animals 
Sprague-Dawley rats and Golden Syrian hamsters were housed in colony cages in a 
room with controlled temperature (20-23°C) and lighting (alternating 12 hour periods 
of light and dark). Prior to the studies, the animals were fed a pelletized commercial 
nonpurified diet for 6 days after arrival. Afterwards, the animals were switched to a 
0.9% high cholesterol diet as previously described in Chapter 2 and 3. 
Thirty rats (190 — 240g) and thirty hamsters were fed a high cholesterol semisynthetic 
diet ad libitum for 4 weeks. The animals were killed by a nitrogen gas tank during the 
mid-dark phase of the light cycle. The liver was rapidly removed and frozen in liquid 
nitrogen. Serum total cholesterol (TC) levels were determined enzymatically by the 
use of commercial kits (Sigma Chemical, St Louis, MO, USA). 
4.3.2 Western blot 
The protein extraction and Western blot were carried out with the procedures 
previously described in Chapter 2 and 3. 
4.3.3 Statistics 
For the serum cholesterol, the statistical significance of differences between groups 
was assessed by Student's Mest, using Prism® (Graphpad software). Differences 
between groups were considered significant when P<0.05. In addition, the correlation 
between protein expression and serum cholesterol in the animal models were assessed 
by correlation analysis, using Prism® (Graphpad software). P value and coefficient of 
determinant (r^) were measured and the result considered as statistically significant 
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4.4 Results 
4.4.1 Growth and food intake 
Table 4.1 showed the changes in body weight and food intake of rats and 
hamsters after one month feeding of a high cholesterol diet. The rats had gained 91 
grams while the hamsters had body weight gained only 4 grams. This was in 
agreement with the observation that the rats consumed 31 grams diet while hamsters 
only had a food intake of 7 grams per day. 
4.4.2 Change of serum cholesterol 
Figure 4.1 showed the change in serum total cholesterol (TC) of rats after feeding rats 
with a 0.9% cholesterol diet for one month. The serum TC of rats increased from 
76.2±2.4 to 93.8±4.9mg/dl {P<0.01\ which represented only 23% increase. In 
contrast, the serum TC of hamsters (Figure 5.2) increased from 110.8士2.1 to 
332.9±9.7mg/dl (P<0.0001), which represented 200% increase (Figure 4.2). 
4.4.3 Correlation between various protein expression and serum cholesterol 
4.43.1 Correlation between LDL-receptor and serum total cholesterol in rats 
Figure 4.3 showed the relative LDL-receptor protein expression against serum 
total cholesterol in rats. The coefficient of determinant (r^) was 0.0044 and the P value 
was larger than 0.72, suggesting that there had no correlation between the 
LDL-receptor expression and serum TC in rats fed a high cholesterol diet. 
4.4.3.2 Correlation between CYP7A1 and serum total cholesterol in rats 
Figure 4.4 showed the correlation between relative CYP7A1 protein expression 
and serum TC in rats. The coefficient of determinant (r^) was 0.3351 and P<0.001, 
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Figure 4.1. The serum total cholesterol of Sprague-Dawley rats fed a 0.9% 
cholesterol diet for one month. Data are mean士S.E.M.; n=30; ** P<0.01 when 
compared with week 0. 
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Figure 4.2. The serum total cholesterol of Golden Syrian hamsters fed a 0.9% 
cholesterol diet for one month. Data are mean士S.E.M.; n=30; *** PO.OOOl when 
compared with week 0. 
102 
I § ^ � 2 = 0 . 0 0 2 5 
§ £ < 3 - • P>0.79 
<0 i c CO 2 . = £ 
a 8 -Q 2 -
X m =5 • 
CD 2 Y 
i> Q £ 1 - • • • 
o - J • V • • 
^ o • • • • 
0 r - ^ — — 丨 • • 丨 . 
0 50 100 150 200 
Serum total cholesterol (mg/dl) 
Figure 4.3. Correlation between the relative protein expression of LDL-receptor and 
serum total cholesterol in rats fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r ) and the P value were shown on the graph. 
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Figure 4.4. Correlation between the relative protein expression of CYP7A1 and 
serum total cholesterol in rats fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r^) and the P value were shown on the graph. 
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level in rats fed a high cholesterol diet. 
4.4.3.3 Correlation between nSREBP-2 and serum total cholesterol in rats 
Figure 4.5 showed the relative nSREBP-2 protein expression against serum total 
cholesterol in rats. The coefficient of determinant (r^) was 0.0224 and the P value was 
larger than 0.43, suggesting that there had no correlation between the nSREBP-2 
expression and serum TC in rats fed a high cholesterol diet. 
4.4.3.4 Correlation between LXR-a and serum total cholesterol in rats 
Figure 4.6 showed the relative LXR-a protein expression against serum total 
cholesterol in rats. The coefficient of determinant (r^) was 0.0002 and the P value was 
larger than 0.94, suggesting that there had no correlation between the nSREBP-2 
expression and serum TC in rats fed a high cholesterol diet. 
4.43.5 Correlation between HMG-CoA reductase and serum total cholesterol in 
rats 
Figure 4.7 showed the relative HMG-CoA reductase protein expression against 
serum total cholesterol in rats. The coefficient of determinant (r^) was 0.0092 and the 
p value was larger than 0.61, suggesting that there had no correlation between the 
nSREBP-2 expression and serum TC in rats fed a high cholesterol diet. 
4.4.3.6 Correlation between LDL-receptor and serum total cholesterol in 
hamsters 
Figure 4.8 showed the correlation between the relative LDL-receptor protein 
expression and serum TC in hamsters. The coefficient of determinant (r^) was 0.3785 
and the P<0.05, indicating that the LDL-receptor expression was negatively 
correlated with serum TC in hamsters. 
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Figure 4.5. Correlation between the relative protein expression of nSREBP-2 and 
serum total cholesterol in rats fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r^) and the P value were shown on the graph. 
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Figure 4.6. Correlation between the relative protein expression of LXR-a and serum 
total cholesterol in rats fed a 0.9 % high cholesterol diet for a month. The coefficient 
of determinant (r^) and the P value were shown on the graph. 
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Figure 4.7. Correlation between the relative protein expression of HMG-CoA 
reductase and serum total cholesterol in rats fed a 0.9 % high cholesterol diet for a 
month. The coefficient of determinant (r^) and the P value were shown on the graph. 
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4.4.3.7 Correlation between CYP7A1 and serum total cholesterol in hamsters 
Figure 4.9 showed the relative CYP7A1 protein expression in relation to serum 
TC in hamsters. The coefficient of determinant (r^) was 0.5556 and P<0.05. The 
present result demonstrated that the CYP7A1 expression was inversely correlated 
with serum TC in hamsters. 
4.4.3.8 Correlation between nSREBP-2 and serum total cholesterol in hamsters 
Figure 4.10 showed the relative nSREBP-2 protein expression in relation to 
serum TC in hamsters. The coefficient of determinant (r^) was 0.0906 and the P value 
was larger than 0.11, suggesting that there had no correlation between the nSREBP-2 
expression and serum TC in hamsters fed a high cholesterol diet 
4,43.9 Correlation between HMG-CoA reductase and serum total cholesterol in 
hamsters 
Figure 4.11 showed the relative HMG-CoA reductase protein expression in 
relation to serum TC in hamsters. The coefficient of determinant (r^) was 0.0631 and 
the P value was larger than 0.19. The present result demonstrated that the HMG-CoA 
reductase expression was inversely correlated with serum TC in hamsters. 
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Figure 4.8. Correlation between the relative protein expression of LDL-receptor and 
serum total cholesterol in hamsters fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r^) and the P value were shown on the graph. 
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Figure 4.9. Correlation between the relative protein expression of CYP7A1 and 
serum total cholesterol in hamsters fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r^) and the P value were shown on the graph. 
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Figure 4.10. Correlation between the relative protein expression of nSREBP-2 and 
serum total cholesterol in hamsters fed a 0.9 % high cholesterol diet for a month. The 
coefficient of determinant (r^) and the P value were shown on the graph. 
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Figure 4.11. Correlation between the relative protein expression of HMG-CoA 
reductase and serum total cholesterol in hamsters fed a 0.9 % high cholesterol diet for 
a month. The coefficient of determinant (r^) and the P value were shown on the graph. 
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4.5 Discussion 
The present study clearly demonstrated that elevation of dietary cholesterol 
raised blood cholesterol in both hamsters and rats. However, serum TC increased only 
by 22% in rats while it raised by 200% in hamsters. In general, elevation of serum TC 
in hamsters was 12-fold higher than that in rats fed the same high cholesterol diet. The 
previous two chapters had examined the molecular mechanism by which why two 
species had their blood cholesterol responded differently to the same high dietary 
cholesterol. The present study was, however, to carry out further on a fundamental 
issue of why some individuals were hyper-responsive while others were 
hypo-responsive to dietary cholesterol within a species. 
Individual rats responded differently to the dietary cholesterol. As shown in 
Figures 4.3, serum TC ranged from 58 to 152mg/dl was observed. When the 
relationship between the relative expression of LDL-receptor and serum cholesterol 
was examined (Figure 4.3), no correlation was found, suggesting that the 
LDL-receptor protein expression is not a limiting factor in regulation of serum 
cholesterol level in rats fed the same level of dietary cholesterol. The present study 
found an inverse correlation between relative CYP7A1 protein expression and the 
level of serum cholesterol in rats (Figure 4.4). For those individuals with lower 
CYP7A1 expression, the serum total cholesterol was higher. The reverse was true for 
those individuals with higher protein expression of CYP7A1 had lower serum total 
cholesterol. The present results indicated that the individual variation in blood 
cholesterol level of rats fed the same amount of dietary cholesterol is dependent at 
least partially on their variation in CYP7A1 expression. Further investigation on the 
correlation between the expressions ofnSREBP-2, LXR-a, HMG-CoA reductase and 
serum cholesterol were examined (Figure 4.5 to 4.7). No correlation was found 
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between the expression of these proteins and the level of serum cholesterol, 
suggesting that the nSREBP-2, LXR-a and HMG-CoA reductase protein expressions 
were not the limiting factors in controlling the serum cholesterol in rats fed a high 
dietary cholesterol. 
Hamsters demonstrated a sharp increase in serum TC on a high cholesterol diet 
for a month. However, individual variation in blood cholesterol was so significant 
with a range of 236 to 457mg/dl (Figure 4.8). Interestingly, an inverse correlation was 
observed between LDL-receptor protein expression and serum cholesterol level in 
hamsters (Figure 4.8). Similarly, CYP7A1 protein expression was also inversely 
correlated with serum cholesterol level (Figure 4.9). The efficient elimination of 
cholesterol from blood is mediated by LDL-receptor and subsequently via CYP7A1 
(classical) pathway, which converts hepatic cholesterol to bile acids. The present 
study demonstrated that both the LDL-receptor and CYP7A1 were the regulatory 
points that were responsible for controlling the blood cholesterol in hamsters. 
However, no correlation between the protein expression of nSREBP-2, HMG-CoA 
reductase and serum total cholesterol was found (Figure 4.10 and 4.11). It was 
concluded that the hyper-responsive hamsters was due to lower expression of both 
LDL-receptor and CYP7A1 while the hypo-responsive ones were due to higher 
expression of these two proteins in hamsters on the same high cholesterol diet. 
The variation in expression of LDL-receptor and CYP7A1 may be attributable to 
the DNA polymorphism. One relevant clinical study conducted in Czech indicated 
that polymorphism in CYP7A1 promoter region was closed linked to some 
hyper-responsive male individuals (Hubacek et al., 2003). For those individuals with 
CYP7A1 homozygous -204A allele, which is a polymorphism in the promoter region 
of CYP7A1, their blood cholesterol level demonstrated a minimal response to dietary 
cholesterol. In contrast, lowering effect on total blood cholesterol was observed in CC 
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homozygotes in response to dietary cholesterol. In addition, several studies also 
indicated that polymorphism of CYP7A1 gene led to different response to dietary 
cholesterol in humans (Wang et al., 1998; Lin et al., 2005). 
It was interesting that some clinical studies had also demonstrated that 
LDL-receptor mutation was related to variation in the serum cholesterol level 
(Umans-Eckenhausen et al., 2002; Humphries et al., 1991; Haviland et al., 1997). 
Although no direct evidence found that the mutation on the promoter region in 
hamsters, the mutation of LDL-receptor gene may disrupt the expression of 
LDL-receptor or the trafficking of it to the liver cell surface. Less LDL-receptor 
expression resulted in less cholesterol uptake from blood, which eventually caused the 
hyper-responsiveness of dietary cholesterol in some individual hamsters. The future 
investigation should focus on identification of LDL-receptor mutation or DNA 




It has been demonstrated that liver plays a very important role in controlling the 
plasma cholesterol level in response to dietary cholesterol, via two pathways: uptake 
from blood via LDL-receptor and elimination to bile acids, via CYP7A1. The 
responsiveness to dietary cholesterol is due to the different ability to utilize these two 
pathways. The following model explains why rats are hypo-responsive to dietary 
cholesterol (Figure 5.1). As dietary cholesterol brings into the liver by LDL-receptor, 
HMG-CoA reductase is inhibited while LXR-a is up-regulated by cholesterol. The 
LXR-a up-regulates CYP7A1, which converts more cholesterol to bile acids. As 
biliary cholesterol binds with bile acids in intestine and hindered the enterohepatic 
circulation of bile acids, a large amount of neutral sterol and bile acids was excreted 
in feces. Therefore, up-regulation CYP7A1 is due to two mechanisms in rats: (i) 
stimulation of LXR-a and, (ii) less negative feedback of bile acids. As a result, a 
cholesterol efflux of cholesterol, driven by conversion of cholesterol to bile acids, 
occurs in the liver. In response to the net cholesterol efflux, more nSREBP-2 is 
formed, which it acts as a transcription factor to up-regulate the transcription of 
LDL-receptor. The up-regulation of both hepatic LDL-receptor and CYP7A1 
generates a cholesterol flux from blood to feces. Liver acts as an intermediate to 
uptake blood cholesterol, which is then being eliminated quickly in feces. Hence, rats 
are hypo-responsive to dietary cholesterol. 
In contrast, hamsters are hyper-responsive to dietary cholesterol because of the 
following mechanism (Figure 5.2). Dietary cholesterol brings into liver by 
LDL-receptor, under physiological condition as in rat. In liver, HMG-CoA reductase 
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is inhibited while LXR-a is not up-regulated by cholesterol. In addition, bile acids are 
being brought back to liver via enterohepatic circulation and inhibit the expression of 
CYP7A1. As a result, CYP7A1 is not up-regulated to convert more cholesterol to bile 
acids and cholesterol flux is not generated in the liver as in rat. Without cholesterol 
efflux, nSREBP-2 and LDL-receptor are not up-regulated. Hence, hamsters are 
hyper-responsive to dietary cholesterol because they do not eliminate cholesterol and 
transport cholesterol from blood to liver efficiently. 
Further efforts had made to investigate the mechanism of individual variation of 
serum cholesterol in response to the same level of dietary cholesterol. The results 
showed that more CYP7A1 protein expression was correlated with the less serum 
cholesterol in both rats and hamsters. However, only LDL-receptor protein expression 
was negatively correlated with serum cholesterol in hamsters. The protein expressions 
of nSREBP-2, LXR-a and HMG-CoA reductase were not correlated with the serum 
total cholesterol in both rats and hamsters. High expression of CYP7A1 and 
LDL-receptor helps individuals eliminate excess cholesterol from body and increase 
uptake of cholesterol from blood, respectively. Therefore, different response to dietary 
cholesterol was observed in individuals with various expression level of these proteins, 
even in the same animal model. 
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Figure 5.1. The mechanism for the hypo-responsiveness of rat to dietary cholesterol. 
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